AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|EVENT_TYPE|POPULATION|SITE|YEAR
0-14|0.3|0.4|0.3|194|Mortality|59955368|Acute Lymphocytic|1999
0-14|3.4|3.7|3.5|2073|Incidence|59151007|Acute Lymphocytic|1999
0-14|0.2|0.3|0.2|141|Mortality|59955368|Acute Myeloid|1999
0-14|0.6|0.7|0.7|398|Incidence|59151007|Acute Myeloid|1999
0-14|2.4|2.6|2.5|1498|Mortality|59955368|All Cancer Sites Combined|1999
0-14|14.2|14.8|14.5|8575|Incidence|59151007|All Cancer Sites Combined|1999
0-14|0.1|0.2|0.1|82|Mortality|59955368|Bones and Joints|1999
0-14|0.7|0.8|0.7|434|Incidence|59151007|Bones and Joints|1999
0-14|0.7|0.8|0.7|431|Mortality|59955368|Brain and Other Nervous System|1999
0-14|3.1|3.4|3.3|1931|Incidence|59151007|Brain and Other Nervous System|1999
0-14|~|~|~|~|Mortality|59955368|Hodgkin Lymphoma|1999
0-14|0.5|0.6|0.5|324|Incidence|59151007|Hodgkin Lymphoma|1999
0-14|0.1|0.1|0.1|54|Mortality|59955368|Kidney and Renal Pelvis|1999
0-14|0.8|0.9|0.8|494|Incidence|59151007|Kidney and Renal Pelvis|1999
0-14|0.7|0.8|0.8|451|Mortality|59955368|Leukemia|1999
0-14|4.3|4.7|4.5|2657|Incidence|59151007|Leukemia|1999
0-14|0.1|0.1|0.1|55|Mortality|59955368|Non-Hodgkin Lymphoma|1999
0-14|0.8|1.0|0.9|526|Incidence|59151007|Non-Hodgkin Lymphoma|1999
0-14|0.5|0.6|0.5|328|Mortality|59955368|Other|1999
0-14|2.8|3.1|2.9|1715|Incidence|59151007|Other|1999
0-14|0.1|0.2|0.1|87|Mortality|59955368|Soft Tissue|1999
0-14|0.8|0.9|0.8|494|Incidence|59151007|Soft Tissue|1999
0-19|0.3|0.4|0.4|285|Mortality|80039970|Acute Lymphocytic|1999
0-19|2.8|3.1|3.0|2338|Incidence|78936986|Acute Lymphocytic|1999
0-19|0.2|0.3|0.3|207|Mortality|80039970|Acute Myeloid|1999
0-19|0.7|0.8|0.7|569|Incidence|78936986|Acute Myeloid|1999
0-19|2.7|2.9|2.8|2243|Mortality|80039970|All Cancer Sites Combined|1999
0-19|15.5|16.1|15.8|12462|Incidence|78936986|All Cancer Sites Combined|1999
0-19|0.2|0.3|0.3|209|Mortality|80039970|Bones and Joints|1999
0-19|0.8|1.0|0.9|708|Incidence|78936986|Bones and Joints|1999
0-19|0.6|0.7|0.7|546|Mortality|80039970|Brain and Other Nervous System|1999
0-19|2.8|3.1|3.0|2331|Incidence|78936986|Brain and Other Nervous System|1999
0-19|0.0|0.1|0.1|41|Mortality|80039970|Hodgkin Lymphoma|1999
0-19|1.1|1.3|1.2|934|Incidence|78936986|Hodgkin Lymphoma|1999
0-19|0.1|0.1|0.1|62|Mortality|80039970|Kidney and Renal Pelvis|1999
0-19|0.6|0.7|0.7|523|Incidence|78936986|Kidney and Renal Pelvis|1999
0-19|0.8|0.9|0.8|672|Mortality|80039970|Leukemia|1999
0-19|3.9|4.2|4.0|3183|Incidence|78936986|Leukemia|1999
0-19|0.1|0.2|0.1|106|Mortality|80039970|Non-Hodgkin Lymphoma|1999
0-19|1.0|1.1|1.1|834|Incidence|78936986|Non-Hodgkin Lymphoma|1999
0-19|0.5|0.6|0.6|455|Mortality|80039970|Other|1999
0-19|4.0|4.3|4.1|3258|Incidence|78936986|Other|1999
0-19|0.2|0.2|0.2|152|Mortality|80039970|Soft Tissue|1999
0-19|0.8|0.9|0.9|691|Incidence|78936986|Soft Tissue|1999
0-14|0.3|0.4|0.4|234|Mortality|60279841|Acute Lymphocytic|2000
0-14|3.5|3.8|3.7|2163|Incidence|59476204|Acute Lymphocytic|2000
0-14|0.2|0.3|0.2|145|Mortality|60279841|Acute Myeloid|2000
0-14|0.5|0.7|0.6|352|Incidence|59476204|Acute Myeloid|2000
0-14|2.4|2.7|2.5|1526|Mortality|60279841|All Cancer Sites Combined|2000
0-14|14.6|15.2|14.9|8842|Incidence|59476204|All Cancer Sites Combined|2000
0-14|0.1|0.2|0.1|83|Mortality|60279841|Bones and Joints|2000
0-14|0.6|0.7|0.7|401|Incidence|59476204|Bones and Joints|2000
0-14|0.7|0.8|0.7|440|Mortality|60279841|Brain and Other Nervous System|2000
0-14|3.2|3.5|3.4|2003|Incidence|59476204|Brain and Other Nervous System|2000
0-14|~|~|~|~|Mortality|60279841|Hodgkin Lymphoma|2000
0-14|0.5|0.6|0.6|348|Incidence|59476204|Hodgkin Lymphoma|2000
0-14|0.1|0.1|0.1|46|Mortality|60279841|Kidney and Renal Pelvis|2000
0-14|0.8|1.0|0.9|529|Incidence|59476204|Kidney and Renal Pelvis|2000
0-14|0.7|0.9|0.8|490|Mortality|60279841|Leukemia|2000
0-14|4.4|4.8|4.6|2717|Incidence|59476204|Leukemia|2000
0-14|0.1|0.1|0.1|55|Mortality|60279841|Non-Hodgkin Lymphoma|2000
0-14|0.9|1.0|0.9|556|Incidence|59476204|Non-Hodgkin Lymphoma|2000
0-14|0.5|0.6|0.6|333|Mortality|60279841|Other|2000
0-14|2.8|3.0|2.9|1720|Incidence|59476204|Other|2000
0-14|0.1|0.1|0.1|71|Mortality|60279841|Soft Tissue|2000
0-14|0.9|1.0|1.0|568|Incidence|59476204|Soft Tissue|2000
0-19|0.4|0.5|0.4|332|Mortality|80574796|Acute Lymphocytic|2000
0-19|3.0|3.3|3.1|2482|Incidence|79474943|Acute Lymphocytic|2000
0-19|0.2|0.3|0.3|222|Mortality|80574796|Acute Myeloid|2000
0-19|0.6|0.7|0.7|520|Incidence|79474943|Acute Myeloid|2000
0-19|2.7|2.9|2.8|2271|Mortality|80574796|All Cancer Sites Combined|2000
0-19|16.0|16.6|16.3|12952|Incidence|79474943|All Cancer Sites Combined|2000
0-19|0.2|0.3|0.2|181|Mortality|80574796|Bones and Joints|2000
0-19|0.8|0.9|0.8|677|Incidence|79474943|Bones and Joints|2000
0-19|0.6|0.7|0.7|545|Mortality|80574796|Brain and Other Nervous System|2000
0-19|3.0|3.2|3.1|2438|Incidence|79474943|Brain and Other Nervous System|2000
0-19|0.0|0.1|0.0|29|Mortality|80574796|Hodgkin Lymphoma|2000
0-19|1.2|1.3|1.2|983|Incidence|79474943|Hodgkin Lymphoma|2000
0-19|0.1|0.1|0.1|54|Mortality|80574796|Kidney and Renal Pelvis|2000
0-19|0.6|0.8|0.7|557|Incidence|79474943|Kidney and Renal Pelvis|2000
0-19|0.8|1.0|0.9|732|Mortality|80574796|Leukemia|2000
0-19|4.0|4.3|4.1|3265|Incidence|79474943|Leukemia|2000
0-19|0.1|0.2|0.1|115|Mortality|80574796|Non-Hodgkin Lymphoma|2000
0-19|1.1|1.2|1.1|907|Incidence|79474943|Non-Hodgkin Lymphoma|2000
0-19|0.5|0.6|0.6|471|Mortality|80574796|Other|2000
0-19|4.0|4.3|4.2|3306|Incidence|79474943|Other|2000
0-19|0.2|0.2|0.2|144|Mortality|80574796|Soft Tissue|2000
0-19|1.0|1.1|1.0|819|Incidence|79474943|Soft Tissue|2000
0-14|0.3|0.4|0.3|208|Mortality|60450257|Acute Lymphocytic|2001
0-14|3.6|4.0|3.8|2249|Incidence|59815030|Acute Lymphocytic|2001
0-14|0.2|0.3|0.3|157|Mortality|60450257|Acute Myeloid|2001
0-14|0.6|0.7|0.7|395|Incidence|59815030|Acute Myeloid|2001
0-14|2.4|2.6|2.5|1494|Mortality|60450257|All Cancer Sites Combined|2001
0-14|15.3|15.9|15.6|9314|Incidence|59815030|All Cancer Sites Combined|2001
0-14|0.1|0.2|0.1|88|Mortality|60450257|Bones and Joints|2001
0-14|0.7|0.8|0.7|433|Incidence|59815030|Bones and Joints|2001
0-14|0.6|0.8|0.7|416|Mortality|60450257|Brain and Other Nervous System|2001
0-14|3.2|3.5|3.3|1997|Incidence|59815030|Brain and Other Nervous System|2001
0-14|~|~|~|~|Mortality|60450257|Hodgkin Lymphoma|2001
0-14|0.5|0.7|0.6|357|Incidence|59815030|Hodgkin Lymphoma|2001
0-14|0.1|0.1|0.1|58|Mortality|60450257|Kidney and Renal Pelvis|2001
0-14|0.8|1.0|0.9|527|Incidence|59815030|Kidney and Renal Pelvis|2001
0-14|0.8|0.9|0.8|503|Mortality|60450257|Leukemia|2001
0-14|4.7|5.0|4.8|2878|Incidence|59815030|Leukemia|2001
0-14|0.0|0.1|0.1|40|Mortality|60450257|Non-Hodgkin Lymphoma|2001
0-14|0.8|1.0|0.9|543|Incidence|59815030|Non-Hodgkin Lymphoma|2001
0-14|0.4|0.6|0.5|297|Mortality|60450257|Other|2001
0-14|3.2|3.5|3.3|1994|Incidence|59815030|Other|2001
0-14|0.1|0.2|0.1|86|Mortality|60450257|Soft Tissue|2001
0-14|0.9|1.1|1.0|585|Incidence|59815030|Soft Tissue|2001
0-19|0.3|0.4|0.4|313|Mortality|80906541|Acute Lymphocytic|2001
0-19|3.1|3.3|3.2|2556|Incidence|80042731|Acute Lymphocytic|2001
0-19|0.2|0.3|0.3|227|Mortality|80906541|Acute Myeloid|2001
0-19|0.7|0.8|0.7|567|Incidence|80042731|Acute Myeloid|2001
0-19|2.6|2.9|2.8|2226|Mortality|80906541|All Cancer Sites Combined|2001
0-19|16.7|17.3|17.0|13628|Incidence|80042731|All Cancer Sites Combined|2001
0-19|0.2|0.3|0.2|189|Mortality|80906541|Bones and Joints|2001
0-19|0.9|1.0|1.0|782|Incidence|80042731|Bones and Joints|2001
0-19|0.6|0.7|0.6|520|Mortality|80906541|Brain and Other Nervous System|2001
0-19|2.9|3.2|3.1|2437|Incidence|80042731|Brain and Other Nervous System|2001
0-19|0.0|0.1|0.0|31|Mortality|80906541|Hodgkin Lymphoma|2001
0-19|1.2|1.3|1.3|1007|Incidence|80042731|Hodgkin Lymphoma|2001
0-19|0.1|0.1|0.1|66|Mortality|80906541|Kidney and Renal Pelvis|2001
0-19|0.6|0.8|0.7|560|Incidence|80042731|Kidney and Renal Pelvis|2001
0-19|0.8|1.0|0.9|728|Mortality|80906541|Leukemia|2001
0-19|4.2|4.5|4.3|3455|Incidence|80042731|Leukemia|2001
0-19|0.1|0.2|0.1|101|Mortality|80906541|Non-Hodgkin Lymphoma|2001
0-19|1.0|1.2|1.1|900|Incidence|80042731|Non-Hodgkin Lymphoma|2001
0-19|0.5|0.6|0.6|444|Mortality|80906541|Other|2001
0-19|4.4|4.7|4.6|3677|Incidence|80042731|Other|2001
0-19|0.2|0.2|0.2|147|Mortality|80906541|Soft Tissue|2001
0-19|0.9|1.1|1.0|810|Incidence|80042731|Soft Tissue|2001
0-14|0.3|0.4|0.4|217|Mortality|60563030|Acute Lymphocytic|2002
0-14|3.5|3.8|3.6|2159|Incidence|59931314|Acute Lymphocytic|2002
0-14|0.2|0.3|0.2|131|Mortality|60563030|Acute Myeloid|2002
0-14|0.6|0.7|0.7|407|Incidence|59931314|Acute Myeloid|2002
0-14|2.4|2.7|2.6|1548|Mortality|60563030|All Cancer Sites Combined|2002
0-14|15.1|15.8|15.5|9265|Incidence|59931314|All Cancer Sites Combined|2002
0-14|0.1|0.2|0.1|85|Mortality|60563030|Bones and Joints|2002
0-14|0.6|0.8|0.7|429|Incidence|59931314|Bones and Joints|2002
0-14|0.7|0.8|0.8|463|Mortality|60563030|Brain and Other Nervous System|2002
0-14|3.4|3.7|3.5|2109|Incidence|59931314|Brain and Other Nervous System|2002
0-14|~|~|~|~|Mortality|60563030|Hodgkin Lymphoma|2002
0-14|0.5|0.6|0.5|335|Incidence|59931314|Hodgkin Lymphoma|2002
0-14|0.1|0.1|0.1|42|Mortality|60563030|Kidney and Renal Pelvis|2002
0-14|0.8|0.9|0.9|507|Incidence|59931314|Kidney and Renal Pelvis|2002
0-14|0.7|0.8|0.7|441|Mortality|60563030|Leukemia|2002
0-14|4.5|4.9|4.7|2816|Incidence|59931314|Leukemia|2002
0-14|0.1|0.2|0.1|74|Mortality|60563030|Non-Hodgkin Lymphoma|2002
0-14|0.8|1.0|0.9|537|Incidence|59931314|Non-Hodgkin Lymphoma|2002
0-14|0.5|0.6|0.6|342|Mortality|60563030|Other|2002
0-14|3.1|3.3|3.2|1928|Incidence|59931314|Other|2002
0-14|0.1|0.2|0.2|95|Mortality|60563030|Soft Tissue|2002
0-14|0.9|1.1|1.0|604|Incidence|59931314|Soft Tissue|2002
0-19|0.4|0.4|0.4|323|Mortality|81173400|Acute Lymphocytic|2002
0-19|3.0|3.2|3.1|2486|Incidence|80317363|Acute Lymphocytic|2002
0-19|0.2|0.3|0.3|209|Mortality|81173400|Acute Myeloid|2002
0-19|0.7|0.8|0.7|575|Incidence|80317363|Acute Myeloid|2002
0-19|2.7|2.9|2.8|2271|Mortality|81173400|All Cancer Sites Combined|2002
0-19|16.8|17.3|17.0|13692|Incidence|80317363|All Cancer Sites Combined|2002
0-19|0.2|0.3|0.2|179|Mortality|81173400|Bones and Joints|2002
0-19|0.9|1.0|0.9|756|Incidence|80317363|Bones and Joints|2002
0-19|0.7|0.8|0.7|571|Mortality|81173400|Brain and Other Nervous System|2002
0-19|3.1|3.3|3.2|2562|Incidence|80317363|Brain and Other Nervous System|2002
0-19|0.0|0.1|0.0|33|Mortality|81173400|Hodgkin Lymphoma|2002
0-19|1.2|1.3|1.2|1003|Incidence|80317363|Hodgkin Lymphoma|2002
0-19|0.0|0.1|0.1|49|Mortality|81173400|Kidney and Renal Pelvis|2002
0-19|0.6|0.7|0.7|535|Incidence|80317363|Kidney and Renal Pelvis|2002
0-19|0.8|0.9|0.8|678|Mortality|81173400|Leukemia|2002
0-19|4.1|4.4|4.2|3390|Incidence|80317363|Leukemia|2002
0-19|0.1|0.2|0.1|118|Mortality|81173400|Non-Hodgkin Lymphoma|2002
0-19|1.1|1.2|1.1|910|Incidence|80317363|Non-Hodgkin Lymphoma|2002
0-19|0.6|0.7|0.6|490|Mortality|81173400|Other|2002
0-19|4.5|4.8|4.6|3714|Incidence|80317363|Other|2002
0-19|0.2|0.2|0.2|153|Mortality|81173400|Soft Tissue|2002
0-19|1.0|1.1|1.0|822|Incidence|80317363|Soft Tissue|2002
0-14|0.4|0.5|0.4|246|Mortality|60628650|Acute Lymphocytic|2003
0-14|3.4|3.7|3.5|2139|Incidence|60628650|Acute Lymphocytic|2003
0-14|0.2|0.3|0.2|142|Mortality|60628650|Acute Myeloid|2003
0-14|0.6|0.7|0.7|397|Incidence|60628650|Acute Myeloid|2003
0-14|2.4|2.7|2.5|1543|Mortality|60628650|All Cancer Sites Combined|2003
0-14|14.9|15.5|15.2|9224|Incidence|60628650|All Cancer Sites Combined|2003
0-14|0.1|0.2|0.1|82|Mortality|60628650|Bones and Joints|2003
0-14|0.6|0.8|0.7|420|Incidence|60628650|Bones and Joints|2003
0-14|0.7|0.8|0.8|458|Mortality|60628650|Brain and Other Nervous System|2003
0-14|3.2|3.5|3.4|2029|Incidence|60628650|Brain and Other Nervous System|2003
0-14|~|~|~|~|Mortality|60628650|Hodgkin Lymphoma|2003
0-14|0.5|0.6|0.6|359|Incidence|60628650|Hodgkin Lymphoma|2003
0-14|0.1|0.1|0.1|54|Mortality|60628650|Kidney and Renal Pelvis|2003
0-14|0.8|0.9|0.9|523|Incidence|60628650|Kidney and Renal Pelvis|2003
0-14|0.8|0.9|0.8|505|Mortality|60628650|Leukemia|2003
0-14|4.4|4.7|4.5|2736|Incidence|60628650|Leukemia|2003
0-14|0.1|0.1|0.1|50|Mortality|60628650|Non-Hodgkin Lymphoma|2003
0-14|0.8|1.0|0.9|543|Incidence|60628650|Non-Hodgkin Lymphoma|2003
0-14|0.5|0.6|0.5|311|Mortality|60628650|Other|2003
0-14|3.2|3.5|3.3|2031|Incidence|60628650|Other|2003
0-14|0.1|0.2|0.1|78|Mortality|60628650|Soft Tissue|2003
0-14|0.9|1.0|1.0|583|Incidence|60628650|Soft Tissue|2003
0-19|0.4|0.4|0.4|328|Mortality|81425816|Acute Lymphocytic|2003
0-19|2.9|3.1|3.0|2436|Incidence|81425816|Acute Lymphocytic|2003
0-19|0.2|0.3|0.3|207|Mortality|81425816|Acute Myeloid|2003
0-19|0.6|0.7|0.7|563|Incidence|81425816|Acute Myeloid|2003
0-19|2.6|2.9|2.7|2233|Mortality|81425816|All Cancer Sites Combined|2003
0-19|16.5|17.0|16.7|13670|Incidence|81425816|All Cancer Sites Combined|2003
0-19|0.2|0.3|0.2|186|Mortality|81425816|Bones and Joints|2003
0-19|0.8|1.0|0.9|732|Incidence|81425816|Bones and Joints|2003
0-19|0.7|0.8|0.7|577|Mortality|81425816|Brain and Other Nervous System|2003
0-19|3.0|3.2|3.1|2493|Incidence|81425816|Brain and Other Nervous System|2003
0-19|0.0|0.0|0.0|21|Mortality|81425816|Hodgkin Lymphoma|2003
0-19|1.2|1.3|1.2|1024|Incidence|81425816|Hodgkin Lymphoma|2003
0-19|0.1|0.1|0.1|65|Mortality|81425816|Kidney and Renal Pelvis|2003
0-19|0.6|0.7|0.7|554|Incidence|81425816|Kidney and Renal Pelvis|2003
0-19|0.8|0.9|0.8|688|Mortality|81425816|Leukemia|2003
0-19|3.9|4.2|4.1|3298|Incidence|81425816|Leukemia|2003
0-19|0.1|0.2|0.1|103|Mortality|81425816|Non-Hodgkin Lymphoma|2003
0-19|1.0|1.1|1.1|877|Incidence|81425816|Non-Hodgkin Lymphoma|2003
0-19|0.5|0.6|0.6|447|Mortality|81425816|Other|2003
0-19|4.5|4.8|4.7|3857|Incidence|81425816|Other|2003
0-19|0.2|0.2|0.2|146|Mortality|81425816|Soft Tissue|2003
0-19|1.0|1.1|1.0|835|Incidence|81425816|Soft Tissue|2003
0-14|0.3|0.4|0.3|202|Mortality|60651802|Acute Lymphocytic|2004
0-14|3.7|4.0|3.8|2322|Incidence|60651802|Acute Lymphocytic|2004
0-14|0.2|0.3|0.2|147|Mortality|60651802|Acute Myeloid|2004
0-14|0.6|0.8|0.7|421|Incidence|60651802|Acute Myeloid|2004
0-14|2.3|2.6|2.5|1492|Mortality|60651802|All Cancer Sites Combined|2004
0-14|15.6|16.3|16.0|9720|Incidence|60651802|All Cancer Sites Combined|2004
0-14|0.1|0.2|0.1|75|Mortality|60651802|Bones and Joints|2004
0-14|0.7|0.8|0.7|452|Incidence|60651802|Bones and Joints|2004
0-14|0.7|0.8|0.7|446|Mortality|60651802|Brain and Other Nervous System|2004
0-14|3.4|3.7|3.6|2174|Incidence|60651802|Brain and Other Nervous System|2004
0-14|~|~|~|~|Mortality|60651802|Hodgkin Lymphoma|2004
0-14|0.5|0.6|0.5|324|Incidence|60651802|Hodgkin Lymphoma|2004
0-14|0.1|0.1|0.1|51|Mortality|60651802|Kidney and Renal Pelvis|2004
0-14|0.8|0.9|0.8|505|Incidence|60651802|Kidney and Renal Pelvis|2004
0-14|0.7|0.8|0.8|455|Mortality|60651802|Leukemia|2004
0-14|4.7|5.1|4.9|2986|Incidence|60651802|Leukemia|2004
0-14|0.1|0.1|0.1|44|Mortality|60651802|Non-Hodgkin Lymphoma|2004
0-14|0.9|1.0|0.9|573|Incidence|60651802|Non-Hodgkin Lymphoma|2004
0-14|0.5|0.6|0.5|317|Mortality|60651802|Other|2004
0-14|3.3|3.6|3.4|2098|Incidence|60651802|Other|2004
0-14|0.1|0.2|0.2|98|Mortality|60651802|Soft Tissue|2004
0-14|0.9|1.1|1.0|608|Incidence|60651802|Soft Tissue|2004
0-19|0.3|0.4|0.4|295|Mortality|81754354|Acute Lymphocytic|2004
0-19|3.2|3.4|3.3|2665|Incidence|81754354|Acute Lymphocytic|2004
0-19|0.2|0.3|0.3|211|Mortality|81754354|Acute Myeloid|2004
0-19|0.7|0.8|0.7|596|Incidence|81754354|Acute Myeloid|2004
0-19|2.6|2.8|2.7|2223|Mortality|81754354|All Cancer Sites Combined|2004
0-19|17.1|17.7|17.4|14310|Incidence|81754354|All Cancer Sites Combined|2004
0-19|0.2|0.3|0.2|189|Mortality|81754354|Bones and Joints|2004
0-19|0.9|1.0|0.9|772|Incidence|81754354|Bones and Joints|2004
0-19|0.6|0.7|0.7|555|Mortality|81754354|Brain and Other Nervous System|2004
0-19|3.2|3.4|3.3|2670|Incidence|81754354|Brain and Other Nervous System|2004
0-19|0.0|0.0|0.0|23|Mortality|81754354|Hodgkin Lymphoma|2004
0-19|1.1|1.3|1.2|990|Incidence|81754354|Hodgkin Lymphoma|2004
0-19|0.1|0.1|0.1|59|Mortality|81754354|Kidney and Renal Pelvis|2004
0-19|0.6|0.7|0.7|547|Incidence|81754354|Kidney and Renal Pelvis|2004
0-19|0.8|0.9|0.8|665|Mortality|81754354|Leukemia|2004
0-19|4.3|4.6|4.4|3591|Incidence|81754354|Leukemia|2004
0-19|0.1|0.1|0.1|100|Mortality|81754354|Non-Hodgkin Lymphoma|2004
0-19|1.0|1.2|1.1|918|Incidence|81754354|Non-Hodgkin Lymphoma|2004
0-19|0.5|0.6|0.6|468|Mortality|81754354|Other|2004
0-19|4.6|4.9|4.8|3965|Incidence|81754354|Other|2004
0-19|0.2|0.2|0.2|164|Mortality|81754354|Soft Tissue|2004
0-19|1.0|1.1|1.0|857|Incidence|81754354|Soft Tissue|2004
0-14|0.3|0.4|0.3|188|Mortality|60519046|Acute Lymphocytic|2005
0-14|3.6|3.9|3.7|2253|Incidence|60519046|Acute Lymphocytic|2005
0-14|0.2|0.3|0.2|137|Mortality|60519046|Acute Myeloid|2005
0-14|0.6|0.7|0.6|390|Incidence|60519046|Acute Myeloid|2005
0-14|2.3|2.5|2.4|1452|Mortality|60519046|All Cancer Sites Combined|2005
0-14|15.3|15.9|15.6|9476|Incidence|60519046|All Cancer Sites Combined|2005
0-14|0.1|0.2|0.1|88|Mortality|60519046|Bones and Joints|2005
0-14|0.6|0.8|0.7|419|Incidence|60519046|Bones and Joints|2005
0-14|0.6|0.8|0.7|426|Mortality|60519046|Brain and Other Nervous System|2005
0-14|3.3|3.6|3.4|2064|Incidence|60519046|Brain and Other Nervous System|2005
0-14|~|~|~|~|Mortality|60519046|Hodgkin Lymphoma|2005
0-14|0.5|0.7|0.6|360|Incidence|60519046|Hodgkin Lymphoma|2005
0-14|0.1|0.1|0.1|54|Mortality|60519046|Kidney and Renal Pelvis|2005
0-14|0.8|0.9|0.9|519|Incidence|60519046|Kidney and Renal Pelvis|2005
0-14|0.6|0.8|0.7|417|Mortality|60519046|Leukemia|2005
0-14|4.6|4.9|4.7|2881|Incidence|60519046|Leukemia|2005
0-14|0.1|0.1|0.1|55|Mortality|60519046|Non-Hodgkin Lymphoma|2005
0-14|0.8|1.0|0.9|551|Incidence|60519046|Non-Hodgkin Lymphoma|2005
0-14|0.5|0.6|0.5|318|Mortality|60519046|Other|2005
0-14|3.2|3.5|3.4|2074|Incidence|60519046|Other|2005
0-14|0.1|0.2|0.1|83|Mortality|60519046|Soft Tissue|2005
0-14|0.9|1.1|1.0|608|Incidence|60519046|Soft Tissue|2005
0-19|0.3|0.4|0.3|267|Mortality|82005260|Acute Lymphocytic|2005
0-19|3.0|3.3|3.2|2583|Incidence|82005260|Acute Lymphocytic|2005
0-19|0.2|0.3|0.3|212|Mortality|82005260|Acute Myeloid|2005
0-19|0.6|0.7|0.7|544|Incidence|82005260|Acute Myeloid|2005
0-19|2.5|2.8|2.7|2183|Mortality|82005260|All Cancer Sites Combined|2005
0-19|17.0|17.5|17.2|14246|Incidence|82005260|All Cancer Sites Combined|2005
0-19|0.2|0.3|0.3|212|Mortality|82005260|Bones and Joints|2005
0-19|0.8|1.0|0.9|747|Incidence|82005260|Bones and Joints|2005
0-19|0.6|0.7|0.7|544|Mortality|82005260|Brain and Other Nervous System|2005
0-19|3.0|3.2|3.1|2541|Incidence|82005260|Brain and Other Nervous System|2005
0-19|0.0|0.0|0.0|22|Mortality|82005260|Hodgkin Lymphoma|2005
0-19|1.2|1.4|1.3|1070|Incidence|82005260|Hodgkin Lymphoma|2005
0-19|0.1|0.1|0.1|62|Mortality|82005260|Kidney and Renal Pelvis|2005
0-19|0.6|0.8|0.7|568|Incidence|82005260|Kidney and Renal Pelvis|2005
0-19|0.7|0.8|0.8|640|Mortality|82005260|Leukemia|2005
0-19|4.1|4.4|4.2|3475|Incidence|82005260|Leukemia|2005
0-19|0.1|0.1|0.1|102|Mortality|82005260|Non-Hodgkin Lymphoma|2005
0-19|1.1|1.2|1.2|964|Incidence|82005260|Non-Hodgkin Lymphoma|2005
0-19|0.5|0.6|0.5|438|Mortality|82005260|Other|2005
0-19|4.7|5.0|4.8|4024|Incidence|82005260|Other|2005
0-19|0.2|0.2|0.2|163|Mortality|82005260|Soft Tissue|2005
0-19|1.0|1.1|1.0|857|Incidence|82005260|Soft Tissue|2005
0-14|0.2|0.3|0.3|174|Mortality|60516709|Acute Lymphocytic|2006
0-14|3.7|4.0|3.9|2344|Incidence|60516709|Acute Lymphocytic|2006
0-14|0.2|0.2|0.2|124|Mortality|60516709|Acute Myeloid|2006
0-14|0.6|0.8|0.7|420|Incidence|60516709|Acute Myeloid|2006
0-14|2.1|2.4|2.2|1360|Mortality|60516709|All Cancer Sites Combined|2006
0-14|15.6|16.2|15.9|9673|Incidence|60516709|All Cancer Sites Combined|2006
0-14|0.1|0.1|0.1|59|Mortality|60516709|Bones and Joints|2006
0-14|0.7|0.8|0.7|439|Incidence|60516709|Bones and Joints|2006
0-14|0.6|0.8|0.7|422|Mortality|60516709|Brain and Other Nervous System|2006
0-14|3.4|3.7|3.5|2126|Incidence|60516709|Brain and Other Nervous System|2006
0-14|~|~|~|~|Mortality|60516709|Hodgkin Lymphoma|2006
0-14|0.6|0.7|0.6|372|Incidence|60516709|Hodgkin Lymphoma|2006
0-14|0.1|0.1|0.1|43|Mortality|60516709|Kidney and Renal Pelvis|2006
0-14|0.8|0.9|0.9|522|Incidence|60516709|Kidney and Renal Pelvis|2006
0-14|0.6|0.7|0.7|411|Mortality|60516709|Leukemia|2006
0-14|4.8|5.1|4.9|3001|Incidence|60516709|Leukemia|2006
0-14|0.1|0.1|0.1|44|Mortality|60516709|Non-Hodgkin Lymphoma|2006
0-14|0.8|1.0|0.9|549|Incidence|60516709|Non-Hodgkin Lymphoma|2006
0-14|0.4|0.5|0.5|296|Mortality|60516709|Other|2006
0-14|3.2|3.5|3.4|2069|Incidence|60516709|Other|2006
0-14|0.1|0.2|0.1|80|Mortality|60516709|Soft Tissue|2006
0-14|0.9|1.1|1.0|595|Incidence|60516709|Soft Tissue|2006
0-19|0.3|0.4|0.3|266|Mortality|82324418|Acute Lymphocytic|2006
0-19|3.2|3.4|3.3|2702|Incidence|82324418|Acute Lymphocytic|2006
0-19|0.2|0.3|0.2|195|Mortality|82324418|Acute Myeloid|2006
0-19|0.7|0.8|0.7|598|Incidence|82324418|Acute Myeloid|2006
0-19|2.4|2.6|2.5|2035|Mortality|82324418|All Cancer Sites Combined|2006
0-19|17.0|17.6|17.3|14384|Incidence|82324418|All Cancer Sites Combined|2006
0-19|0.2|0.2|0.2|174|Mortality|82324418|Bones and Joints|2006
0-19|0.9|1.0|1.0|796|Incidence|82324418|Bones and Joints|2006
0-19|0.6|0.7|0.6|524|Mortality|82324418|Brain and Other Nervous System|2006
0-19|3.1|3.3|3.2|2636|Incidence|82324418|Brain and Other Nervous System|2006
0-19|0.0|0.0|0.0|23|Mortality|82324418|Hodgkin Lymphoma|2006
0-19|1.2|1.3|1.2|1057|Incidence|82324418|Hodgkin Lymphoma|2006
0-19|0.1|0.1|0.1|54|Mortality|82324418|Kidney and Renal Pelvis|2006
0-19|0.6|0.8|0.7|570|Incidence|82324418|Kidney and Renal Pelvis|2006
0-19|0.7|0.8|0.7|618|Mortality|82324418|Leukemia|2006
0-19|4.3|4.6|4.4|3655|Incidence|82324418|Leukemia|2006
0-19|0.1|0.1|0.1|89|Mortality|82324418|Non-Hodgkin Lymphoma|2006
0-19|1.1|1.2|1.1|945|Incidence|82324418|Non-Hodgkin Lymphoma|2006
0-19|0.5|0.6|0.5|413|Mortality|82324418|Other|2006
0-19|4.5|4.8|4.6|3900|Incidence|82324418|Other|2006
0-19|0.1|0.2|0.2|140|Mortality|82324418|Soft Tissue|2006
0-19|0.9|1.1|1.0|825|Incidence|82324418|Soft Tissue|2006
0-14|0.3|0.4|0.4|212|Mortality|60681615|Acute Lymphocytic|2007
0-14|3.8|4.1|4.0|2409|Incidence|60681615|Acute Lymphocytic|2007
0-14|0.2|0.3|0.2|129|Mortality|60681615|Acute Myeloid|2007
0-14|0.6|0.7|0.7|412|Incidence|60681615|Acute Myeloid|2007
0-14|2.2|2.4|2.3|1395|Mortality|60681615|All Cancer Sites Combined|2007
0-14|15.9|16.5|16.2|9905|Incidence|60681615|All Cancer Sites Combined|2007
0-14|0.1|0.1|0.1|61|Mortality|60681615|Bones and Joints|2007
0-14|0.6|0.8|0.7|427|Incidence|60681615|Bones and Joints|2007
0-14|0.6|0.8|0.7|426|Mortality|60681615|Brain and Other Nervous System|2007
0-14|3.5|3.8|3.7|2220|Incidence|60681615|Brain and Other Nervous System|2007
0-14|~|~|~|~|Mortality|60681615|Hodgkin Lymphoma|2007
0-14|0.5|0.6|0.5|332|Incidence|60681615|Hodgkin Lymphoma|2007
0-14|0.0|0.1|0.1|36|Mortality|60681615|Kidney and Renal Pelvis|2007
0-14|0.8|1.0|0.9|543|Incidence|60681615|Kidney and Renal Pelvis|2007
0-14|0.7|0.8|0.7|441|Mortality|60681615|Leukemia|2007
0-14|4.8|5.2|5.0|3049|Incidence|60681615|Leukemia|2007
0-14|0.0|0.1|0.1|40|Mortality|60681615|Non-Hodgkin Lymphoma|2007
0-14|0.9|1.1|1.0|595|Incidence|60681615|Non-Hodgkin Lymphoma|2007
0-14|0.4|0.6|0.5|306|Mortality|60681615|Other|2007
0-14|3.2|3.5|3.4|2085|Incidence|60681615|Other|2007
0-14|0.1|0.2|0.1|82|Mortality|60681615|Soft Tissue|2007
0-14|1.0|1.1|1.1|654|Incidence|60681615|Soft Tissue|2007
0-19|0.3|0.4|0.4|294|Mortality|82749431|Acute Lymphocytic|2007
0-19|3.3|3.5|3.4|2776|Incidence|82749431|Acute Lymphocytic|2007
0-19|0.2|0.3|0.2|195|Mortality|82749431|Acute Myeloid|2007
0-19|0.6|0.8|0.7|581|Incidence|82749431|Acute Myeloid|2007
0-19|2.4|2.6|2.5|2068|Mortality|82749431|All Cancer Sites Combined|2007
0-19|17.4|18.0|17.7|14801|Incidence|82749431|All Cancer Sites Combined|2007
0-19|0.2|0.2|0.2|172|Mortality|82749431|Bones and Joints|2007
0-19|0.8|1.0|0.9|752|Incidence|82749431|Bones and Joints|2007
0-19|0.6|0.7|0.6|521|Mortality|82749431|Brain and Other Nervous System|2007
0-19|3.2|3.4|3.3|2721|Incidence|82749431|Brain and Other Nervous System|2007
0-19|0.0|0.0|0.0|19|Mortality|82749431|Hodgkin Lymphoma|2007
0-19|1.1|1.3|1.2|1038|Incidence|82749431|Hodgkin Lymphoma|2007
0-19|0.0|0.1|0.1|47|Mortality|82749431|Kidney and Renal Pelvis|2007
0-19|0.7|0.8|0.7|587|Incidence|82749431|Kidney and Renal Pelvis|2007
0-19|0.7|0.8|0.8|643|Mortality|82749431|Leukemia|2007
0-19|4.3|4.6|4.5|3699|Incidence|82749431|Leukemia|2007
0-19|0.1|0.1|0.1|87|Mortality|82749431|Non-Hodgkin Lymphoma|2007
0-19|1.1|1.2|1.2|976|Incidence|82749431|Non-Hodgkin Lymphoma|2007
0-19|0.5|0.6|0.5|439|Mortality|82749431|Other|2007
0-19|4.7|5.0|4.8|4103|Incidence|82749431|Other|2007
0-19|0.1|0.2|0.2|140|Mortality|82749431|Soft Tissue|2007
0-19|1.0|1.2|1.1|925|Incidence|82749431|Soft Tissue|2007
0-14|0.2|0.3|0.3|176|Mortality|60907384|Acute Lymphocytic|2008
0-14|3.9|4.2|4.1|2488|Incidence|60907384|Acute Lymphocytic|2008
0-14|0.2|0.2|0.2|127|Mortality|60907384|Acute Myeloid|2008
0-14|0.6|0.8|0.7|436|Incidence|60907384|Acute Myeloid|2008
0-14|2.1|2.3|2.2|1354|Mortality|60907384|All Cancer Sites Combined|2008
0-14|16.1|16.8|16.5|10104|Incidence|60907384|All Cancer Sites Combined|2008
0-14|0.1|0.1|0.1|62|Mortality|60907384|Bones and Joints|2008
0-14|0.6|0.8|0.7|424|Incidence|60907384|Bones and Joints|2008
0-14|0.6|0.8|0.7|429|Mortality|60907384|Brain and Other Nervous System|2008
0-14|3.5|3.8|3.7|2232|Incidence|60907384|Brain and Other Nervous System|2008
0-14|~|~|~|~|Mortality|60907384|Hodgkin Lymphoma|2008
0-14|0.6|0.7|0.6|383|Incidence|60907384|Hodgkin Lymphoma|2008
0-14|0.1|0.1|0.1|46|Mortality|60907384|Kidney and Renal Pelvis|2008
0-14|0.8|1.0|0.9|570|Incidence|60907384|Kidney and Renal Pelvis|2008
0-14|0.6|0.7|0.7|402|Mortality|60907384|Leukemia|2008
0-14|5.0|5.3|5.1|3149|Incidence|60907384|Leukemia|2008
0-14|0.0|0.1|0.1|39|Mortality|60907384|Non-Hodgkin Lymphoma|2008
0-14|0.9|1.0|1.0|583|Incidence|60907384|Non-Hodgkin Lymphoma|2008
0-14|0.4|0.5|0.5|286|Mortality|60907384|Other|2008
0-14|3.2|3.5|3.4|2096|Incidence|60907384|Other|2008
0-14|0.1|0.2|0.1|89|Mortality|60907384|Soft Tissue|2008
0-14|1.0|1.2|1.1|667|Incidence|60907384|Soft Tissue|2008
0-19|0.3|0.3|0.3|253|Mortality|83118264|Acute Lymphocytic|2008
0-19|3.3|3.6|3.5|2860|Incidence|83118264|Acute Lymphocytic|2008
0-19|0.2|0.3|0.2|183|Mortality|83118264|Acute Myeloid|2008
0-19|0.7|0.8|0.7|629|Incidence|83118264|Acute Myeloid|2008
0-19|2.3|2.5|2.4|2039|Mortality|83118264|All Cancer Sites Combined|2008
0-19|17.6|18.2|17.9|15032|Incidence|83118264|All Cancer Sites Combined|2008
0-19|0.2|0.2|0.2|182|Mortality|83118264|Bones and Joints|2008
0-19|0.8|1.0|0.9|750|Incidence|83118264|Bones and Joints|2008
0-19|0.6|0.7|0.6|533|Mortality|83118264|Brain and Other Nervous System|2008
0-19|3.2|3.5|3.3|2757|Incidence|83118264|Brain and Other Nervous System|2008
0-19|~|~|~|~|Mortality|83118264|Hodgkin Lymphoma|2008
0-19|1.2|1.4|1.3|1102|Incidence|83118264|Hodgkin Lymphoma|2008
0-19|0.0|0.1|0.1|52|Mortality|83118264|Kidney and Renal Pelvis|2008
0-19|0.7|0.8|0.7|619|Incidence|83118264|Kidney and Renal Pelvis|2008
0-19|0.7|0.8|0.7|598|Mortality|83118264|Leukemia|2008
0-19|4.5|4.8|4.6|3826|Incidence|83118264|Leukemia|2008
0-19|0.1|0.1|0.1|93|Mortality|83118264|Non-Hodgkin Lymphoma|2008
0-19|1.1|1.2|1.2|964|Incidence|83118264|Non-Hodgkin Lymphoma|2008
0-19|0.4|0.5|0.5|407|Mortality|83118264|Other|2008
0-19|4.7|4.9|4.8|4097|Incidence|83118264|Other|2008
0-19|0.2|0.2|0.2|160|Mortality|83118264|Soft Tissue|2008
0-19|1.0|1.2|1.1|917|Incidence|83118264|Soft Tissue|2008
0-14|0.2|0.3|0.3|174|Mortality|61087581|Acute Lymphocytic|2009
0-14|3.9|4.2|4.1|2514|Incidence|61087581|Acute Lymphocytic|2009
0-14|0.2|0.2|0.2|119|Mortality|61087581|Acute Myeloid|2009
0-14|0.6|0.7|0.6|397|Incidence|61087581|Acute Myeloid|2009
0-14|2.0|2.3|2.2|1320|Mortality|61087581|All Cancer Sites Combined|2009
0-14|16.0|16.7|16.4|10053|Incidence|61087581|All Cancer Sites Combined|2009
0-14|0.1|0.2|0.1|77|Mortality|61087581|Bones and Joints|2009
0-14|0.6|0.8|0.7|431|Incidence|61087581|Bones and Joints|2009
0-14|0.6|0.7|0.7|402|Mortality|61087581|Brain and Other Nervous System|2009
0-14|3.5|3.8|3.6|2227|Incidence|61087581|Brain and Other Nervous System|2009
0-14|~|~|~|~|Mortality|61087581|Hodgkin Lymphoma|2009
0-14|0.5|0.6|0.6|349|Incidence|61087581|Hodgkin Lymphoma|2009
0-14|0.0|0.1|0.1|38|Mortality|61087581|Kidney and Renal Pelvis|2009
0-14|0.9|1.0|1.0|592|Incidence|61087581|Kidney and Renal Pelvis|2009
0-14|0.6|0.7|0.6|389|Mortality|61087581|Leukemia|2009
0-14|4.9|5.3|5.1|3129|Incidence|61087581|Leukemia|2009
0-14|0.0|0.1|0.1|38|Mortality|61087581|Non-Hodgkin Lymphoma|2009
0-14|0.9|1.0|0.9|573|Incidence|61087581|Non-Hodgkin Lymphoma|2009
0-14|0.4|0.5|0.4|271|Mortality|61087581|Other|2009
0-14|3.3|3.6|3.4|2105|Incidence|61087581|Other|2009
0-14|0.1|0.2|0.2|98|Mortality|61087581|Soft Tissue|2009
0-14|1.0|1.1|1.1|647|Incidence|61087581|Soft Tissue|2009
0-19|0.3|0.3|0.3|240|Mortality|83280391|Acute Lymphocytic|2009
0-19|3.3|3.6|3.5|2864|Incidence|83280391|Acute Lymphocytic|2009
0-19|0.2|0.3|0.2|182|Mortality|83280391|Acute Myeloid|2009
0-19|0.6|0.7|0.7|574|Incidence|83280391|Acute Myeloid|2009
0-19|2.2|2.5|2.3|1964|Mortality|83280391|All Cancer Sites Combined|2009
0-19|17.6|18.1|17.9|14998|Incidence|83280391|All Cancer Sites Combined|2009
0-19|0.2|0.2|0.2|179|Mortality|83280391|Bones and Joints|2009
0-19|0.8|1.0|0.9|763|Incidence|83280391|Bones and Joints|2009
0-19|0.6|0.7|0.6|522|Mortality|83280391|Brain and Other Nervous System|2009
0-19|3.2|3.4|3.3|2728|Incidence|83280391|Brain and Other Nervous System|2009
0-19|0.0|0.0|0.0|22|Mortality|83280391|Hodgkin Lymphoma|2009
0-19|1.2|1.3|1.3|1086|Incidence|83280391|Hodgkin Lymphoma|2009
0-19|0.0|0.1|0.1|45|Mortality|83280391|Kidney and Renal Pelvis|2009
0-19|0.7|0.8|0.8|636|Incidence|83280391|Kidney and Renal Pelvis|2009
0-19|0.6|0.7|0.7|561|Mortality|83280391|Leukemia|2009
0-19|4.4|4.7|4.5|3754|Incidence|83280391|Leukemia|2009
0-19|0.1|0.1|0.1|75|Mortality|83280391|Non-Hodgkin Lymphoma|2009
0-19|1.1|1.2|1.1|946|Incidence|83280391|Non-Hodgkin Lymphoma|2009
0-19|0.4|0.5|0.5|396|Mortality|83280391|Other|2009
0-19|4.7|5.0|4.9|4162|Incidence|83280391|Other|2009
0-19|0.2|0.2|0.2|164|Mortality|83280391|Soft Tissue|2009
0-19|1.0|1.2|1.1|923|Incidence|83280391|Soft Tissue|2009
0-14|0.2|0.3|0.3|164|Mortality|61210239|Acute Lymphocytic|2010
0-14|3.9|4.2|4.1|2516|Incidence|61210239|Acute Lymphocytic|2010
0-14|0.2|0.3|0.2|131|Mortality|61210239|Acute Myeloid|2010
0-14|0.6|0.8|0.7|435|Incidence|61210239|Acute Myeloid|2010
0-14|2.0|2.3|2.2|1324|Mortality|61210239|All Cancer Sites Combined|2010
0-14|16.8|17.4|17.1|10506|Incidence|61210239|All Cancer Sites Combined|2010
0-14|0.1|0.2|0.1|75|Mortality|61210239|Bones and Joints|2010
0-14|0.6|0.8|0.7|425|Incidence|61210239|Bones and Joints|2010
0-14|0.6|0.7|0.7|410|Mortality|61210239|Brain and Other Nervous System|2010
0-14|3.6|3.9|3.8|2305|Incidence|61210239|Brain and Other Nervous System|2010
0-14|~|~|~|~|Mortality|61210239|Hodgkin Lymphoma|2010
0-14|0.5|0.6|0.5|323|Incidence|61210239|Hodgkin Lymphoma|2010
0-14|0.1|0.1|0.1|46|Mortality|61210239|Kidney and Renal Pelvis|2010
0-14|0.8|0.9|0.9|540|Incidence|61210239|Kidney and Renal Pelvis|2010
0-14|0.6|0.7|0.6|390|Mortality|61210239|Leukemia|2010
0-14|5.0|5.3|5.1|3164|Incidence|61210239|Leukemia|2010
0-14|0.0|0.1|0.1|35|Mortality|61210239|Non-Hodgkin Lymphoma|2010
0-14|0.9|1.1|1.0|593|Incidence|61210239|Non-Hodgkin Lymphoma|2010
0-14|0.4|0.5|0.5|286|Mortality|61210239|Other|2010
0-14|3.9|4.2|4.1|2495|Incidence|61210239|Other|2010
0-14|0.1|0.2|0.1|79|Mortality|61210239|Soft Tissue|2010
0-14|1.0|1.2|1.1|661|Incidence|61210239|Soft Tissue|2010
0-19|0.2|0.3|0.3|230|Mortality|83218950|Acute Lymphocytic|2010
0-19|3.3|3.6|3.4|2851|Incidence|83218950|Acute Lymphocytic|2010
0-19|0.2|0.3|0.2|198|Mortality|83218950|Acute Myeloid|2010
0-19|0.7|0.8|0.8|636|Incidence|83218950|Acute Myeloid|2010
0-19|2.2|2.4|2.3|1925|Mortality|83218950|All Cancer Sites Combined|2010
0-19|18.0|18.6|18.3|15303|Incidence|83218950|All Cancer Sites Combined|2010
0-19|0.2|0.2|0.2|166|Mortality|83218950|Bones and Joints|2010
0-19|0.8|0.9|0.9|716|Incidence|83218950|Bones and Joints|2010
0-19|0.6|0.7|0.6|498|Mortality|83218950|Brain and Other Nervous System|2010
0-19|3.2|3.5|3.4|2784|Incidence|83218950|Brain and Other Nervous System|2010
0-19|~|~|~|~|Mortality|83218950|Hodgkin Lymphoma|2010
0-19|1.1|1.3|1.2|1035|Incidence|83218950|Hodgkin Lymphoma|2010
0-19|0.1|0.1|0.1|56|Mortality|83218950|Kidney and Renal Pelvis|2010
0-19|0.6|0.7|0.7|574|Incidence|83218950|Kidney and Renal Pelvis|2010
0-19|0.6|0.7|0.7|553|Mortality|83218950|Leukemia|2010
0-19|4.4|4.7|4.6|3807|Incidence|83218950|Leukemia|2010
0-19|0.1|0.1|0.1|75|Mortality|83218950|Non-Hodgkin Lymphoma|2010
0-19|1.1|1.2|1.1|951|Incidence|83218950|Non-Hodgkin Lymphoma|2010
0-19|0.5|0.6|0.5|419|Mortality|83218950|Other|2010
0-19|5.2|5.5|5.4|4526|Incidence|83218950|Other|2010
0-19|0.1|0.2|0.2|146|Mortality|83218950|Soft Tissue|2010
0-19|1.0|1.2|1.1|910|Incidence|83218950|Soft Tissue|2010
0-14|0.2|0.3|0.3|153|Mortality|61216474|Acute Lymphocytic|2011
0-14|4.0|4.3|4.2|2572|Incidence|61216474|Acute Lymphocytic|2011
0-14|0.2|0.2|0.2|117|Mortality|61216474|Acute Myeloid|2011
0-14|0.6|0.8|0.7|427|Incidence|61216474|Acute Myeloid|2011
0-14|2.0|2.2|2.1|1283|Mortality|61216474|All Cancer Sites Combined|2011
0-14|16.7|17.4|17.1|10484|Incidence|61216474|All Cancer Sites Combined|2011
0-14|0.1|0.2|0.1|73|Mortality|61216474|Bones and Joints|2011
0-14|0.7|0.8|0.8|464|Incidence|61216474|Bones and Joints|2011
0-14|0.7|0.8|0.7|439|Mortality|61216474|Brain and Other Nervous System|2011
0-14|3.6|3.9|3.7|2271|Incidence|61216474|Brain and Other Nervous System|2011
0-14|~|~|~|~|Mortality|61216474|Hodgkin Lymphoma|2011
0-14|0.5|0.6|0.5|318|Incidence|61216474|Hodgkin Lymphoma|2011
0-14|0.0|0.1|0.1|39|Mortality|61216474|Kidney and Renal Pelvis|2011
0-14|0.9|1.0|0.9|574|Incidence|61216474|Kidney and Renal Pelvis|2011
0-14|0.5|0.6|0.6|342|Mortality|61216474|Leukemia|2011
0-14|5.0|5.4|5.2|3205|Incidence|61216474|Leukemia|2011
0-14|0.0|0.1|0.1|32|Mortality|61216474|Non-Hodgkin Lymphoma|2011
0-14|0.8|1.0|0.9|560|Incidence|61216474|Non-Hodgkin Lymphoma|2011
0-14|0.4|0.5|0.4|273|Mortality|61216474|Other|2011
0-14|3.9|4.2|4.0|2474|Incidence|61216474|Other|2011
0-14|0.1|0.2|0.1|84|Mortality|61216474|Soft Tissue|2011
0-14|0.9|1.1|1.0|618|Incidence|61216474|Soft Tissue|2011
0-19|0.2|0.3|0.3|223|Mortality|83011324|Acute Lymphocytic|2011
0-19|3.4|3.7|3.6|2945|Incidence|83011324|Acute Lymphocytic|2011
0-19|0.2|0.2|0.2|174|Mortality|83011324|Acute Myeloid|2011
0-19|0.7|0.8|0.8|634|Incidence|83011324|Acute Myeloid|2011
0-19|2.2|2.4|2.3|1922|Mortality|83011324|All Cancer Sites Combined|2011
0-19|18.1|18.7|18.4|15381|Incidence|83011324|All Cancer Sites Combined|2011
0-19|0.2|0.2|0.2|174|Mortality|83011324|Bones and Joints|2011
0-19|0.8|1.0|0.9|760|Incidence|83011324|Bones and Joints|2011
0-19|0.6|0.7|0.7|550|Mortality|83011324|Brain and Other Nervous System|2011
0-19|3.3|3.5|3.4|2834|Incidence|83011324|Brain and Other Nervous System|2011
0-19|0.0|0.0|0.0|17|Mortality|83011324|Hodgkin Lymphoma|2011
0-19|1.1|1.3|1.2|1007|Incidence|83011324|Hodgkin Lymphoma|2011
0-19|0.0|0.1|0.1|45|Mortality|83011324|Kidney and Renal Pelvis|2011
0-19|0.7|0.8|0.7|618|Incidence|83011324|Kidney and Renal Pelvis|2011
0-19|0.6|0.7|0.6|519|Mortality|83011324|Leukemia|2011
0-19|4.5|4.8|4.7|3886|Incidence|83011324|Leukemia|2011
0-19|0.1|0.1|0.1|64|Mortality|83011324|Non-Hodgkin Lymphoma|2011
0-19|1.0|1.2|1.1|934|Incidence|83011324|Non-Hodgkin Lymphoma|2011
0-19|0.4|0.5|0.5|405|Mortality|83011324|Other|2011
0-19|5.2|5.5|5.3|4493|Incidence|83011324|Other|2011
0-19|0.1|0.2|0.2|148|Mortality|83011324|Soft Tissue|2011
0-19|1.0|1.1|1.0|849|Incidence|83011324|Soft Tissue|2011
0-14|0.2|0.3|0.2|152|Mortality|61199744|Acute Lymphocytic|2012
0-14|3.8|4.2|4.0|2455|Incidence|61199744|Acute Lymphocytic|2012
0-14|0.2|0.3|0.2|137|Mortality|61199744|Acute Myeloid|2012
0-14|0.6|0.7|0.6|396|Incidence|61199744|Acute Myeloid|2012
0-14|2.1|2.4|2.2|1367|Mortality|61199744|All Cancer Sites Combined|2012
0-14|16.7|17.3|17.0|10427|Incidence|61199744|All Cancer Sites Combined|2012
0-14|0.1|0.1|0.1|68|Mortality|61199744|Bones and Joints|2012
0-14|0.7|0.8|0.7|458|Incidence|61199744|Bones and Joints|2012
0-14|0.7|0.8|0.7|458|Mortality|61199744|Brain and Other Nervous System|2012
0-14|3.5|3.8|3.7|2246|Incidence|61199744|Brain and Other Nervous System|2012
0-14|~|~|~|~|Mortality|61199744|Hodgkin Lymphoma|2012
0-14|0.5|0.6|0.6|349|Incidence|61199744|Hodgkin Lymphoma|2012
0-14|0.0|0.1|0.0|30|Mortality|61199744|Kidney and Renal Pelvis|2012
0-14|0.8|1.0|0.9|544|Incidence|61199744|Kidney and Renal Pelvis|2012
0-14|0.6|0.7|0.6|378|Mortality|61199744|Leukemia|2012
0-14|4.8|5.1|5.0|3049|Incidence|61199744|Leukemia|2012
0-14|0.0|0.1|0.1|36|Mortality|61199744|Non-Hodgkin Lymphoma|2012
0-14|0.9|1.1|1.0|619|Incidence|61199744|Non-Hodgkin Lymphoma|2012
0-14|0.4|0.5|0.5|292|Mortality|61199744|Other|2012
0-14|3.9|4.3|4.1|2520|Incidence|61199744|Other|2012
0-14|0.1|0.2|0.2|101|Mortality|61199744|Soft Tissue|2012
0-14|1.0|1.1|1.0|642|Incidence|61199744|Soft Tissue|2012
0-19|0.2|0.3|0.3|219|Mortality|82811054|Acute Lymphocytic|2012
0-19|3.2|3.5|3.4|2785|Incidence|82811054|Acute Lymphocytic|2012
0-19|0.2|0.3|0.2|193|Mortality|82811054|Acute Myeloid|2012
0-19|0.7|0.8|0.7|595|Incidence|82811054|Acute Myeloid|2012
0-19|2.3|2.5|2.4|1995|Mortality|82811054|All Cancer Sites Combined|2012
0-19|18.2|18.8|18.5|15422|Incidence|82811054|All Cancer Sites Combined|2012
0-19|0.2|0.2|0.2|178|Mortality|82811054|Bones and Joints|2012
0-19|0.9|1.0|0.9|771|Incidence|82811054|Bones and Joints|2012
0-19|0.6|0.8|0.7|575|Mortality|82811054|Brain and Other Nervous System|2012
0-19|3.2|3.5|3.3|2755|Incidence|82811054|Brain and Other Nervous System|2012
0-19|~|~|~|~|Mortality|82811054|Hodgkin Lymphoma|2012
0-19|1.2|1.3|1.2|1047|Incidence|82811054|Hodgkin Lymphoma|2012
0-19|0.0|0.1|0.0|40|Mortality|82811054|Kidney and Renal Pelvis|2012
0-19|0.7|0.8|0.7|599|Incidence|82811054|Kidney and Renal Pelvis|2012
0-19|0.6|0.7|0.6|534|Mortality|82811054|Leukemia|2012
0-19|4.3|4.6|4.5|3692|Incidence|82811054|Leukemia|2012
0-19|0.1|0.1|0.1|60|Mortality|82811054|Non-Hodgkin Lymphoma|2012
0-19|1.2|1.3|1.2|1041|Incidence|82811054|Non-Hodgkin Lymphoma|2012
0-19|0.5|0.6|0.5|421|Mortality|82811054|Other|2012
0-19|5.4|5.7|5.6|4666|Incidence|82811054|Other|2012
0-19|0.2|0.2|0.2|177|Mortality|82811054|Soft Tissue|2012
0-19|1.0|1.1|1.0|851|Incidence|82811054|Soft Tissue|2012
0-14|0.2|0.3|0.2|141|Mortality|61192420|Acute Lymphocytic|2013
0-14|3.6|3.9|3.8|2318|Incidence|61192420|Acute Lymphocytic|2013
0-14|0.2|0.2|0.2|127|Mortality|61192420|Acute Myeloid|2013
0-14|0.7|0.8|0.7|441|Incidence|61192420|Acute Myeloid|2013
0-14|2.0|2.2|2.1|1287|Mortality|61192420|All Cancer Sites Combined|2013
0-14|16.9|17.6|17.3|10568|Incidence|61192420|All Cancer Sites Combined|2013
0-14|0.1|0.1|0.1|72|Mortality|61192420|Bones and Joints|2013
0-14|0.7|0.8|0.8|472|Incidence|61192420|Bones and Joints|2013
0-14|0.6|0.8|0.7|437|Mortality|61192420|Brain and Other Nervous System|2013
0-14|3.6|4.0|3.8|2327|Incidence|61192420|Brain and Other Nervous System|2013
0-14|~|~|~|~|Mortality|61192420|Hodgkin Lymphoma|2013
0-14|0.5|0.6|0.6|339|Incidence|61192420|Hodgkin Lymphoma|2013
0-14|0.0|0.1|0.1|40|Mortality|61192420|Kidney and Renal Pelvis|2013
0-14|0.8|1.0|0.9|557|Incidence|61192420|Kidney and Renal Pelvis|2013
0-14|0.5|0.6|0.6|350|Mortality|61192420|Leukemia|2013
0-14|4.7|5.1|4.9|2997|Incidence|61192420|Leukemia|2013
0-14|0.0|0.1|0.0|29|Mortality|61192420|Non-Hodgkin Lymphoma|2013
0-14|0.9|1.1|1.0|603|Incidence|61192420|Non-Hodgkin Lymphoma|2013
0-14|0.4|0.5|0.4|254|Mortality|61192420|Other|2013
0-14|4.1|4.4|4.3|2608|Incidence|61192420|Other|2013
0-14|0.1|0.2|0.2|101|Mortality|61192420|Soft Tissue|2013
0-14|1.0|1.2|1.1|665|Incidence|61192420|Soft Tissue|2013
0-19|0.2|0.3|0.2|197|Mortality|82716398|Acute Lymphocytic|2013
0-19|3.1|3.3|3.2|2653|Incidence|82716398|Acute Lymphocytic|2013
0-19|0.2|0.3|0.2|186|Mortality|82716398|Acute Myeloid|2013
0-19|0.7|0.8|0.8|634|Incidence|82716398|Acute Myeloid|2013
0-19|2.2|2.4|2.3|1914|Mortality|82716398|All Cancer Sites Combined|2013
0-19|18.1|18.7|18.4|15294|Incidence|82716398|All Cancer Sites Combined|2013
0-19|0.2|0.2|0.2|180|Mortality|82716398|Bones and Joints|2013
0-19|0.9|1.0|0.9|786|Incidence|82716398|Bones and Joints|2013
0-19|0.6|0.7|0.7|556|Mortality|82716398|Brain and Other Nervous System|2013
0-19|3.3|3.6|3.4|2829|Incidence|82716398|Brain and Other Nervous System|2013
0-19|~|~|~|~|Mortality|82716398|Hodgkin Lymphoma|2013
0-19|1.1|1.2|1.1|966|Incidence|82716398|Hodgkin Lymphoma|2013
0-19|0.0|0.1|0.1|46|Mortality|82716398|Kidney and Renal Pelvis|2013
0-19|0.7|0.8|0.7|614|Incidence|82716398|Kidney and Renal Pelvis|2013
0-19|0.6|0.7|0.6|509|Mortality|82716398|Leukemia|2013
0-19|4.3|4.6|4.4|3642|Incidence|82716398|Leukemia|2013
0-19|0.1|0.1|0.1|60|Mortality|82716398|Non-Hodgkin Lymphoma|2013
0-19|1.1|1.2|1.2|970|Incidence|82716398|Non-Hodgkin Lymphoma|2013
0-19|0.4|0.5|0.4|367|Mortality|82716398|Other|2013
0-19|5.4|5.7|5.5|4603|Incidence|82716398|Other|2013
0-19|0.2|0.3|0.2|183|Mortality|82716398|Soft Tissue|2013
0-19|1.0|1.1|1.1|884|Incidence|82716398|Soft Tissue|2013
0-14|0.2|0.3|0.2|141|Mortality|61215749|Acute Lymphocytic|2014
0-14|3.7|4.0|3.9|2368|Incidence|61215749|Acute Lymphocytic|2014
0-14|0.1|0.2|0.2|94|Mortality|61215749|Acute Myeloid|2014
0-14|0.7|0.8|0.7|447|Incidence|61215749|Acute Myeloid|2014
0-14|1.9|2.1|2.0|1225|Mortality|61215749|All Cancer Sites Combined|2014
0-14|17.3|17.9|17.6|10791|Incidence|61215749|All Cancer Sites Combined|2014
0-14|0.1|0.2|0.1|85|Mortality|61215749|Bones and Joints|2014
0-14|0.7|0.9|0.8|494|Incidence|61215749|Bones and Joints|2014
0-14|0.6|0.8|0.7|420|Mortality|61215749|Brain and Other Nervous System|2014
0-14|3.6|3.9|3.8|2316|Incidence|61215749|Brain and Other Nervous System|2014
0-14|~|~|~|~|Mortality|61215749|Hodgkin Lymphoma|2014
0-14|0.5|0.6|0.5|337|Incidence|61215749|Hodgkin Lymphoma|2014
0-14|0.0|0.1|0.0|24|Mortality|61215749|Kidney and Renal Pelvis|2014
0-14|0.9|1.0|0.9|574|Incidence|61215749|Kidney and Renal Pelvis|2014
0-14|0.4|0.5|0.5|296|Mortality|61215749|Leukemia|2014
0-14|4.8|5.2|5.0|3045|Incidence|61215749|Leukemia|2014
0-14|0.0|0.1|0.1|39|Mortality|61215749|Non-Hodgkin Lymphoma|2014
0-14|1.1|1.2|1.1|694|Incidence|61215749|Non-Hodgkin Lymphoma|2014
0-14|0.4|0.5|0.5|285|Mortality|61215749|Other|2014
0-14|4.2|4.5|4.4|2676|Incidence|61215749|Other|2014
0-14|0.1|0.2|0.1|76|Mortality|61215749|Soft Tissue|2014
0-14|1.0|1.2|1.1|655|Incidence|61215749|Soft Tissue|2014
0-19|0.2|0.3|0.2|207|Mortality|82718202|Acute Lymphocytic|2014
0-19|3.2|3.4|3.3|2722|Incidence|82718202|Acute Lymphocytic|2014
0-19|0.2|0.2|0.2|148|Mortality|82718202|Acute Myeloid|2014
0-19|0.7|0.9|0.8|658|Incidence|82718202|Acute Myeloid|2014
0-19|2.1|2.3|2.2|1837|Mortality|82718202|All Cancer Sites Combined|2014
0-19|18.7|19.3|19.0|15758|Incidence|82718202|All Cancer Sites Combined|2014
0-19|0.2|0.2|0.2|181|Mortality|82718202|Bones and Joints|2014
0-19|0.9|1.0|1.0|792|Incidence|82718202|Bones and Joints|2014
0-19|0.6|0.7|0.7|559|Mortality|82718202|Brain and Other Nervous System|2014
0-19|3.3|3.6|3.4|2830|Incidence|82718202|Brain and Other Nervous System|2014
0-19|~|~|~|~|Mortality|82718202|Hodgkin Lymphoma|2014
0-19|1.1|1.2|1.2|988|Incidence|82718202|Hodgkin Lymphoma|2014
0-19|0.0|0.1|0.0|34|Mortality|82718202|Kidney and Renal Pelvis|2014
0-19|0.7|0.8|0.8|624|Incidence|82718202|Kidney and Renal Pelvis|2014
0-19|0.5|0.6|0.5|456|Mortality|82718202|Leukemia|2014
0-19|4.4|4.7|4.5|3726|Incidence|82718202|Leukemia|2014
0-19|0.1|0.1|0.1|69|Mortality|82718202|Non-Hodgkin Lymphoma|2014
0-19|1.3|1.5|1.4|1140|Incidence|82718202|Non-Hodgkin Lymphoma|2014
0-19|0.4|0.5|0.5|389|Mortality|82718202|Other|2014
0-19|5.5|5.9|5.7|4761|Incidence|82718202|Other|2014
0-19|0.1|0.2|0.2|143|Mortality|82718202|Soft Tissue|2014
0-19|1.0|1.2|1.1|897|Incidence|82718202|Soft Tissue|2014
0-14|0.2|0.3|0.2|146|Mortality|61199724|Acute Lymphocytic|2015
0-14|4.0|4.3|4.1|2518|Incidence|61199724|Acute Lymphocytic|2015
0-14|0.2|0.2|0.2|119|Mortality|61199724|Acute Myeloid|2015
0-14|0.7|0.8|0.7|448|Incidence|61199724|Acute Myeloid|2015
0-14|2.0|2.2|2.1|1272|Mortality|61199724|All Cancer Sites Combined|2015
0-14|17.6|18.2|17.9|10972|Incidence|61199724|All Cancer Sites Combined|2015
0-14|0.1|0.2|0.1|84|Mortality|61199724|Bones and Joints|2015
0-14|0.7|0.9|0.8|481|Incidence|61199724|Bones and Joints|2015
0-14|0.6|0.8|0.7|430|Mortality|61199724|Brain and Other Nervous System|2015
0-14|3.5|3.8|3.7|2238|Incidence|61199724|Brain and Other Nervous System|2015
0-14|~|~|~|~|Mortality|61199724|Hodgkin Lymphoma|2015
0-14|0.5|0.7|0.6|360|Incidence|61199724|Hodgkin Lymphoma|2015
0-14|0.0|0.1|0.1|36|Mortality|61199724|Kidney and Renal Pelvis|2015
0-14|0.9|1.1|1.0|610|Incidence|61199724|Kidney and Renal Pelvis|2015
0-14|0.5|0.6|0.6|343|Mortality|61199724|Leukemia|2015
0-14|5.0|5.4|5.2|3183|Incidence|61199724|Leukemia|2015
0-14|0.0|0.1|0.1|35|Mortality|61199724|Non-Hodgkin Lymphoma|2015
0-14|0.9|1.1|1.0|625|Incidence|61199724|Non-Hodgkin Lymphoma|2015
0-14|0.3|0.4|0.4|235|Mortality|61199724|Other|2015
0-14|4.4|4.8|4.6|2811|Incidence|61199724|Other|2015
0-14|0.1|0.2|0.2|105|Mortality|61199724|Soft Tissue|2015
0-14|1.0|1.2|1.1|664|Incidence|61199724|Soft Tissue|2015
0-19|0.2|0.3|0.2|206|Mortality|82835167|Acute Lymphocytic|2015
0-19|3.4|3.7|3.5|2908|Incidence|82835167|Acute Lymphocytic|2015
0-19|0.2|0.2|0.2|175|Mortality|82835167|Acute Myeloid|2015
0-19|0.7|0.8|0.8|637|Incidence|82835167|Acute Myeloid|2015
0-19|2.1|2.3|2.2|1855|Mortality|82835167|All Cancer Sites Combined|2015
0-19|19.2|19.8|19.5|16230|Incidence|82835167|All Cancer Sites Combined|2015
0-19|0.2|0.3|0.2|197|Mortality|82835167|Bones and Joints|2015
0-19|0.9|1.0|0.9|785|Incidence|82835167|Bones and Joints|2015
0-19|0.6|0.7|0.6|531|Mortality|82835167|Brain and Other Nervous System|2015
0-19|3.2|3.5|3.3|2754|Incidence|82835167|Brain and Other Nervous System|2015
0-19|~|~|~|~|Mortality|82835167|Hodgkin Lymphoma|2015
0-19|1.1|1.3|1.2|1028|Incidence|82835167|Hodgkin Lymphoma|2015
0-19|0.0|0.1|0.1|44|Mortality|82835167|Kidney and Renal Pelvis|2015
0-19|0.7|0.9|0.8|663|Incidence|82835167|Kidney and Renal Pelvis|2015
0-19|0.5|0.6|0.6|490|Mortality|82835167|Leukemia|2015
0-19|4.6|4.9|4.7|3881|Incidence|82835167|Leukemia|2015
0-19|0.1|0.1|0.1|73|Mortality|82835167|Non-Hodgkin Lymphoma|2015
0-19|1.2|1.3|1.3|1051|Incidence|82835167|Non-Hodgkin Lymphoma|2015
0-19|0.4|0.5|0.4|350|Mortality|82835167|Other|2015
0-19|6.0|6.3|6.1|5134|Incidence|82835167|Other|2015
0-19|0.2|0.2|0.2|158|Mortality|82835167|Soft Tissue|2015
0-19|1.1|1.2|1.1|934|Incidence|82835167|Soft Tissue|2015
0-14|0.2|0.3|0.2|146|Mortality|61225721|Acute Lymphocytic|2016
0-14|4.0|4.3|4.1|2539|Incidence|61225721|Acute Lymphocytic|2016
0-14|0.2|0.3|0.2|133|Mortality|61225721|Acute Myeloid|2016
0-14|0.7|0.8|0.8|464|Incidence|61225721|Acute Myeloid|2016
0-14|2.0|2.3|2.2|1324|Mortality|61225721|All Cancer Sites Combined|2016
0-14|17.4|18.1|17.7|10867|Incidence|61225721|All Cancer Sites Combined|2016
0-14|0.1|0.2|0.1|82|Mortality|61225721|Bones and Joints|2016
0-14|0.8|0.9|0.8|506|Incidence|61225721|Bones and Joints|2016
0-14|0.7|0.8|0.7|444|Mortality|61225721|Brain and Other Nervous System|2016
0-14|3.6|3.9|3.7|2270|Incidence|61225721|Brain and Other Nervous System|2016
0-14|~|~|~|~|Mortality|61225721|Hodgkin Lymphoma|2016
0-14|0.5|0.6|0.6|352|Incidence|61225721|Hodgkin Lymphoma|2016
0-14|0.0|0.1|0.1|38|Mortality|61225721|Kidney and Renal Pelvis|2016
0-14|0.8|1.0|0.9|540|Incidence|61225721|Kidney and Renal Pelvis|2016
0-14|0.5|0.6|0.6|351|Mortality|61225721|Leukemia|2016
0-14|5.1|5.4|5.3|3223|Incidence|61225721|Leukemia|2016
0-14|0.0|0.1|0.1|31|Mortality|61225721|Non-Hodgkin Lymphoma|2016
0-14|1.0|1.2|1.1|666|Incidence|61225721|Non-Hodgkin Lymphoma|2016
0-14|0.4|0.5|0.4|269|Mortality|61225721|Other|2016
0-14|4.2|4.5|4.3|2665|Incidence|61225721|Other|2016
0-14|0.1|0.2|0.2|107|Mortality|61225721|Soft Tissue|2016
0-14|1.0|1.1|1.1|645|Incidence|61225721|Soft Tissue|2016
0-19|0.2|0.3|0.3|218|Mortality|83018369|Acute Lymphocytic|2016
0-19|3.4|3.7|3.5|2923|Incidence|83018369|Acute Lymphocytic|2016
0-19|0.2|0.2|0.2|179|Mortality|83018369|Acute Myeloid|2016
0-19|0.7|0.9|0.8|659|Incidence|83018369|Acute Myeloid|2016
0-19|2.2|2.4|2.3|1920|Mortality|83018369|All Cancer Sites Combined|2016
0-19|19.0|19.6|19.3|16091|Incidence|83018369|All Cancer Sites Combined|2016
0-19|0.2|0.3|0.2|200|Mortality|83018369|Bones and Joints|2016
0-19|0.9|1.1|1.0|833|Incidence|83018369|Bones and Joints|2016
0-19|0.6|0.7|0.7|552|Mortality|83018369|Brain and Other Nervous System|2016
0-19|3.2|3.4|3.3|2719|Incidence|83018369|Brain and Other Nervous System|2016
0-19|~|~|~|~|Mortality|83018369|Hodgkin Lymphoma|2016
0-19|1.2|1.3|1.2|1042|Incidence|83018369|Hodgkin Lymphoma|2016
0-19|0.0|0.1|0.1|51|Mortality|83018369|Kidney and Renal Pelvis|2016
0-19|0.7|0.8|0.7|585|Incidence|83018369|Kidney and Renal Pelvis|2016
0-19|0.5|0.7|0.6|499|Mortality|83018369|Leukemia|2016
0-19|4.6|4.9|4.7|3904|Incidence|83018369|Leukemia|2016
0-19|0.1|0.1|0.1|60|Mortality|83018369|Non-Hodgkin Lymphoma|2016
0-19|1.2|1.4|1.3|1085|Incidence|83018369|Non-Hodgkin Lymphoma|2016
0-19|0.4|0.5|0.5|385|Mortality|83018369|Other|2016
0-19|5.8|6.1|6.0|5018|Incidence|83018369|Other|2016
0-19|0.2|0.2|0.2|167|Mortality|83018369|Soft Tissue|2016
0-19|1.0|1.2|1.1|905|Incidence|83018369|Soft Tissue|2016
0-14|0.2|0.2|0.2|122|Mortality|61252063|Acute Lymphocytic|2017
0-14|3.8|4.1|3.9|2407|Incidence|61252063|Acute Lymphocytic|2017
0-14|0.2|0.2|0.2|128|Mortality|61252063|Acute Myeloid|2017
0-14|0.6|0.8|0.7|426|Incidence|61252063|Acute Myeloid|2017
0-14|1.9|2.1|2.0|1237|Mortality|61252063|All Cancer Sites Combined|2017
0-14|17.0|17.7|17.3|10615|Incidence|61252063|All Cancer Sites Combined|2017
0-14|0.1|0.1|0.1|67|Mortality|61252063|Bones and Joints|2017
0-14|0.7|0.8|0.8|479|Incidence|61252063|Bones and Joints|2017
0-14|0.6|0.8|0.7|422|Mortality|61252063|Brain and Other Nervous System|2017
0-14|3.7|4.0|3.9|2357|Incidence|61252063|Brain and Other Nervous System|2017
0-14|~|~|~|~|Mortality|61252063|Hodgkin Lymphoma|2017
0-14|0.5|0.6|0.6|353|Incidence|61252063|Hodgkin Lymphoma|2017
0-14|0.0|0.1|0.1|38|Mortality|61252063|Kidney and Renal Pelvis|2017
0-14|0.8|1.0|0.9|539|Incidence|61252063|Kidney and Renal Pelvis|2017
0-14|0.5|0.6|0.5|315|Mortality|61252063|Leukemia|2017
0-14|4.8|5.1|5.0|3043|Incidence|61252063|Leukemia|2017
0-14|0.0|0.1|0.1|34|Mortality|61252063|Non-Hodgkin Lymphoma|2017
0-14|0.9|1.1|1.0|614|Incidence|61252063|Non-Hodgkin Lymphoma|2017
0-14|0.4|0.5|0.4|258|Mortality|61252063|Other|2017
0-14|4.1|4.4|4.3|2605|Incidence|61252063|Other|2017
0-14|0.1|0.2|0.2|102|Mortality|61252063|Soft Tissue|2017
0-14|0.9|1.1|1.0|625|Incidence|61252063|Soft Tissue|2017
0-19|0.2|0.3|0.2|181|Mortality|83117707|Acute Lymphocytic|2017
0-19|3.2|3.5|3.3|2754|Incidence|83117707|Acute Lymphocytic|2017
0-19|0.2|0.3|0.2|187|Mortality|83117707|Acute Myeloid|2017
0-19|0.7|0.8|0.7|600|Incidence|83117707|Acute Myeloid|2017
0-19|2.1|2.3|2.2|1797|Mortality|83117707|All Cancer Sites Combined|2017
0-19|18.5|19.0|18.7|15644|Incidence|83117707|All Cancer Sites Combined|2017
0-19|0.2|0.2|0.2|171|Mortality|83117707|Bones and Joints|2017
0-19|0.9|1.0|1.0|806|Incidence|83117707|Bones and Joints|2017
0-19|0.6|0.7|0.6|519|Mortality|83117707|Brain and Other Nervous System|2017
0-19|3.4|3.6|3.5|2891|Incidence|83117707|Brain and Other Nervous System|2017
0-19|~|~|~|~|Mortality|83117707|Hodgkin Lymphoma|2017
0-19|1.1|1.3|1.2|1015|Incidence|83117707|Hodgkin Lymphoma|2017
0-19|0.0|0.1|0.1|47|Mortality|83117707|Kidney and Renal Pelvis|2017
0-19|0.7|0.8|0.7|582|Incidence|83117707|Kidney and Renal Pelvis|2017
0-19|0.5|0.6|0.6|460|Mortality|83117707|Leukemia|2017
0-19|4.3|4.6|4.4|3678|Incidence|83117707|Leukemia|2017
0-19|0.1|0.1|0.1|58|Mortality|83117707|Non-Hodgkin Lymphoma|2017
0-19|1.1|1.3|1.2|1023|Incidence|83117707|Non-Hodgkin Lymphoma|2017
0-19|0.4|0.5|0.4|368|Mortality|83117707|Other|2017
0-19|5.5|5.8|5.7|4753|Incidence|83117707|Other|2017
0-19|0.2|0.2|0.2|164|Mortality|83117707|Soft Tissue|2017
0-19|1.0|1.1|1.1|896|Incidence|83117707|Soft Tissue|2017
0-14|3.9|4.1|4.0|11872|Incidence|297351811|Acute Lymphocytic|2017-2021
0-14|0.7|0.7|0.7|2056|Incidence|297351811|Acute Myeloid|2017-2021
0-14|16.6|16.9|16.8|49783|Incidence|297351811|All Cancer Sites Combined|2017-2021
0-14|0.7|0.8|0.8|2286|Incidence|297351811|Bones and Joints|2017-2021
0-14|3.3|3.5|3.4|10046|Incidence|297351811|Brain and Other Nervous System|2017-2021
0-14|0.5|0.6|0.6|1673|Incidence|297351811|Hodgkin Lymphoma|2017-2021
0-14|0.8|0.9|0.9|2581|Incidence|297351811|Kidney and Renal Pelvis|2017-2021
0-14|4.9|5.1|5.0|14865|Incidence|297351811|Leukemia|2017-2021
0-14|1.0|1.1|1.0|3074|Incidence|297351811|Non-Hodgkin Lymphoma|2017-2021
0-14|4.1|4.2|4.1|12217|Incidence|297351811|Other|2017-2021
0-14|1.0|1.1|1.0|3041|Incidence|297351811|Soft Tissue|2017-2021
0-19|3.4|3.5|3.4|13758|Incidence|404367531|Acute Lymphocytic|2017-2021
0-19|0.7|0.7|0.7|2927|Incidence|404367531|Acute Myeloid|2017-2021
0-19|18.2|18.5|18.4|74508|Incidence|404367531|All Cancer Sites Combined|2017-2021
0-19|0.9|1.0|0.9|3847|Incidence|404367531|Bones and Joints|2017-2021
0-19|3.0|3.2|3.1|12436|Incidence|404367531|Brain and Other Nervous System|2017-2021
0-19|1.2|1.2|1.2|4956|Incidence|404367531|Hodgkin Lymphoma|2017-2021
0-19|0.7|0.7|0.7|2809|Incidence|404367531|Kidney and Renal Pelvis|2017-2021
0-19|4.5|4.6|4.5|18120|Incidence|404367531|Leukemia|2017-2021
0-19|1.2|1.3|1.2|5019|Incidence|404367531|Non-Hodgkin Lymphoma|2017-2021
0-19|5.6|5.7|5.6|23081|Incidence|404367531|Other|2017-2021
0-19|1.0|1.1|1.1|4240|Incidence|404367531|Soft Tissue|2017-2021
0-14|4.0|4.3|4.1|2514|Incidence|61163353|Acute Lymphocytic|2018
0-14|0.6|0.8|0.7|428|Incidence|61163353|Acute Myeloid|2018
0-14|17.0|17.7|17.3|10594|Incidence|61163353|All Cancer Sites Combined|2018
0-14|0.7|0.9|0.8|507|Incidence|61163353|Bones and Joints|2018
0-14|3.3|3.6|3.5|2111|Incidence|61163353|Brain and Other Nervous System|2018
0-14|0.5|0.7|0.6|368|Incidence|61163353|Hodgkin Lymphoma|2018
0-14|0.8|1.0|0.9|535|Incidence|61163353|Kidney and Renal Pelvis|2018
0-14|5.0|5.4|5.2|3169|Incidence|61163353|Leukemia|2018
0-14|1.0|1.1|1.0|635|Incidence|61163353|Non-Hodgkin Lymphoma|2018
0-14|4.2|4.5|4.4|2669|Incidence|61163353|Other|2018
0-14|0.9|1.1|1.0|600|Incidence|61163353|Soft Tissue|2018
0-19|3.4|3.7|3.6|2942|Incidence|83111569|Acute Lymphocytic|2018
0-19|0.7|0.8|0.7|599|Incidence|83111569|Acute Myeloid|2018
0-19|18.6|19.2|18.9|15735|Incidence|83111569|All Cancer Sites Combined|2018
0-19|0.9|1.1|1.0|831|Incidence|83111569|Bones and Joints|2018
0-19|3.0|3.3|3.1|2588|Incidence|83111569|Brain and Other Nervous System|2018
0-19|1.1|1.3|1.2|1036|Incidence|83111569|Hodgkin Lymphoma|2018
0-19|0.7|0.8|0.7|580|Incidence|83111569|Kidney and Renal Pelvis|2018
0-19|4.5|4.8|4.7|3875|Incidence|83111569|Leukemia|2018
0-19|1.1|1.3|1.2|1012|Incidence|83111569|Non-Hodgkin Lymphoma|2018
0-19|5.8|6.1|5.9|4984|Incidence|83111569|Other|2018
0-19|0.9|1.1|1.0|829|Incidence|83111569|Soft Tissue|2018
0-14|3.8|4.1|3.9|2377|Incidence|60935670|Acute Lymphocytic|2019
0-14|0.7|0.8|0.7|441|Incidence|60935670|Acute Myeloid|2019
0-14|16.4|17.0|16.7|10167|Incidence|60935670|All Cancer Sites Combined|2019
0-14|0.7|0.9|0.8|495|Incidence|60935670|Bones and Joints|2019
0-14|3.1|3.4|3.3|1987|Incidence|60935670|Brain and Other Nervous System|2019
0-14|0.5|0.6|0.6|343|Incidence|60935670|Hodgkin Lymphoma|2019
0-14|0.7|0.9|0.8|487|Incidence|60935670|Kidney and Renal Pelvis|2019
0-14|4.8|5.1|4.9|2996|Incidence|60935670|Leukemia|2019
0-14|0.9|1.0|1.0|588|Incidence|60935670|Non-Hodgkin Lymphoma|2019
0-14|4.1|4.5|4.3|2604|Incidence|60935670|Other|2019
0-14|1.0|1.2|1.1|667|Incidence|60935670|Soft Tissue|2019
0-19|3.2|3.5|3.4|2762|Incidence|82986327|Acute Lymphocytic|2019
0-19|0.7|0.8|0.7|616|Incidence|82986327|Acute Myeloid|2019
0-19|18.2|18.7|18.4|15372|Incidence|82986327|All Cancer Sites Combined|2019
0-19|0.9|1.0|0.9|792|Incidence|82986327|Bones and Joints|2019
0-19|2.9|3.1|3.0|2465|Incidence|82986327|Brain and Other Nervous System|2019
0-19|1.1|1.3|1.2|1041|Incidence|82986327|Hodgkin Lymphoma|2019
0-19|0.6|0.7|0.7|540|Incidence|82986327|Kidney and Renal Pelvis|2019
0-19|4.3|4.6|4.4|3657|Incidence|82986327|Leukemia|2019
0-19|1.1|1.3|1.2|989|Incidence|82986327|Non-Hodgkin Lymphoma|2019
0-19|5.7|6.0|5.9|4945|Incidence|82986327|Other|2019
0-19|1.1|1.2|1.1|943|Incidence|82986327|Soft Tissue|2019
0-14|3.9|4.3|4.1|2415|Incidence|59287487|Acute Lymphocytic|2020
0-14|0.6|0.7|0.7|399|Incidence|59287487|Acute Myeloid|2020
0-14|15.9|16.5|16.2|9574|Incidence|59287487|All Cancer Sites Combined|2020
0-14|0.6|0.7|0.7|403|Incidence|59287487|Bones and Joints|2020
0-14|3.0|3.2|3.1|1830|Incidence|59287487|Brain and Other Nervous System|2020
0-14|0.5|0.6|0.5|319|Incidence|59287487|Hodgkin Lymphoma|2020
0-14|0.8|1.0|0.9|537|Incidence|59287487|Kidney and Renal Pelvis|2020
0-14|4.9|5.3|5.1|2988|Incidence|59287487|Leukemia|2020
0-14|0.9|1.1|1.0|590|Incidence|59287487|Non-Hodgkin Lymphoma|2020
0-14|3.8|4.1|4.0|2325|Incidence|59287487|Other|2020
0-14|0.9|1.1|1.0|582|Incidence|59287487|Soft Tissue|2020
0-19|3.4|3.6|3.5|2783|Incidence|80749239|Acute Lymphocytic|2020
0-19|0.6|0.8|0.7|570|Incidence|80749239|Acute Myeloid|2020
0-19|17.5|18.0|17.7|14360|Incidence|80749239|All Cancer Sites Combined|2020
0-19|0.8|0.9|0.9|719|Incidence|80749239|Bones and Joints|2020
0-19|2.8|3.0|2.9|2315|Incidence|80749239|Brain and Other Nervous System|2020
0-19|1.1|1.2|1.1|957|Incidence|80749239|Hodgkin Lymphoma|2020
0-19|0.7|0.8|0.7|582|Incidence|80749239|Kidney and Renal Pelvis|2020
0-19|4.4|4.7|4.5|3609|Incidence|80749239|Leukemia|2020
0-19|1.1|1.3|1.2|984|Incidence|80749239|Non-Hodgkin Lymphoma|2020
0-19|5.2|5.5|5.4|4388|Incidence|80749239|Other|2020
0-19|0.9|1.1|1.0|806|Incidence|80749239|Soft Tissue|2020
0-14|3.8|4.1|3.9|2285|Incidence|58633693|Acute Lymphocytic|2021
0-14|0.6|0.7|0.7|385|Incidence|58633693|Acute Myeloid|2021
0-14|15.9|16.5|16.2|9449|Incidence|58633693|All Cancer Sites Combined|2021
0-14|0.7|0.8|0.7|440|Incidence|58633693|Bones and Joints|2021
0-14|3.1|3.4|3.3|1903|Incidence|58633693|Brain and Other Nervous System|2021
0-14|0.5|0.6|0.5|311|Incidence|58633693|Hodgkin Lymphoma|2021
0-14|0.8|1.0|0.9|518|Incidence|58633693|Kidney and Renal Pelvis|2021
0-14|4.7|5.0|4.8|2822|Incidence|58633693|Leukemia|2021
0-14|1.1|1.2|1.2|683|Incidence|58633693|Non-Hodgkin Lymphoma|2021
0-14|3.6|3.9|3.7|2159|Incidence|58633693|Other|2021
0-14|1.0|1.1|1.1|613|Incidence|58633693|Soft Tissue|2021
0-19|3.3|3.5|3.4|2664|Incidence|79740141|Acute Lymphocytic|2021
0-19|0.7|0.8|0.7|572|Incidence|79740141|Acute Myeloid|2021
0-19|17.6|18.2|17.9|14296|Incidence|79740141|All Cancer Sites Combined|2021
0-19|0.9|1.0|0.9|753|Incidence|79740141|Bones and Joints|2021
0-19|2.9|3.1|3.0|2352|Incidence|79740141|Brain and Other Nervous System|2021
0-19|1.1|1.2|1.2|967|Incidence|79740141|Hodgkin Lymphoma|2021
0-19|0.7|0.8|0.7|564|Incidence|79740141|Kidney and Renal Pelvis|2021
0-19|4.3|4.6|4.4|3484|Incidence|79740141|Leukemia|2021
0-19|1.3|1.4|1.3|1073|Incidence|79740141|Non-Hodgkin Lymphoma|2021
0-19|5.2|5.5|5.3|4275|Incidence|79740141|Other|2021
0-19|1.0|1.1|1.0|828|Incidence|79740141|Soft Tissue|2021
0-14|0.2|0.2|0.2|118|Mortality|60879327|Acute Lymphocytic|2018
0-14|0.2|0.2|0.2|127|Mortality|60879327|Acute Myeloid|2018
0-14|1.9|2.1|2.0|1220|Mortality|60879327|All Cancer Sites Combined|2018
0-14|0.1|0.2|0.2|97|Mortality|60879327|Bones and Joints|2018
0-14|0.6|0.7|0.7|409|Mortality|60879327|Brain and Other Nervous System|2018
0-14|~|~|~|~|Mortality|60879327|Hodgkin Lymphoma|2018
0-14|0.0|0.1|0.1|41|Mortality|60879327|Kidney and Renal Pelvis|2018
0-14|0.4|0.5|0.5|297|Mortality|60879327|Leukemia|2018
0-14|0.0|0.1|0.0|29|Mortality|60879327|Non-Hodgkin Lymphoma|2018
0-14|0.3|0.4|0.4|233|Mortality|60879327|Other|2018
0-14|0.1|0.2|0.2|111|Mortality|60879327|Soft Tissue|2018
0-19|0.2|0.3|0.2|196|Mortality|81956393|Acute Lymphocytic|2018
0-19|0.2|0.3|0.2|178|Mortality|81956393|Acute Myeloid|2018
0-19|2.1|2.3|2.2|1841|Mortality|81956393|All Cancer Sites Combined|2018
0-19|0.2|0.3|0.2|195|Mortality|81956393|Bones and Joints|2018
0-19|0.6|0.7|0.7|532|Mortality|81956393|Brain and Other Nervous System|2018
0-19|~|~|~|~|Mortality|81956393|Hodgkin Lymphoma|2018
0-19|0.0|0.1|0.1|50|Mortality|81956393|Kidney and Renal Pelvis|2018
0-19|0.5|0.6|0.6|459|Mortality|81956393|Leukemia|2018
0-19|0.1|0.1|0.1|55|Mortality|81956393|Non-Hodgkin Lymphoma|2018
0-19|0.4|0.5|0.4|346|Mortality|81956393|Other|2018
0-19|0.2|0.3|0.2|192|Mortality|81956393|Soft Tissue|2018
0-14|0.2|0.2|0.2|639|Mortality|301448619|Acute Lymphocytic|2018-2022
0-14|0.2|0.2|0.2|526|Mortality|301448619|Acute Myeloid|2018-2022
0-14|1.9|2.0|1.9|5759|Mortality|301448619|All Cancer Sites Combined|2018-2022
0-14|0.1|0.2|0.1|420|Mortality|301448619|Bones and Joints|2018-2022
0-14|0.6|0.7|0.6|1941|Mortality|301448619|Brain and Other Nervous System|2018-2022
0-14|~|~|~|~|Mortality|301448619|Hodgkin Lymphoma|2018-2022
0-14|0.1|0.1|0.1|197|Mortality|301448619|Kidney and Renal Pelvis|2018-2022
0-14|0.4|0.5|0.5|1425|Mortality|301448619|Leukemia|2018-2022
0-14|0.0|0.0|0.0|124|Mortality|301448619|Non-Hodgkin Lymphoma|2018-2022
0-14|0.4|0.4|0.4|1165|Mortality|301448619|Other|2018-2022
0-14|0.1|0.2|0.2|480|Mortality|301448619|Soft Tissue|2018-2022
0-19|0.2|0.3|0.2|967|Mortality|408731990|Acute Lymphocytic|2018-2022
0-19|0.2|0.2|0.2|731|Mortality|408731990|Acute Myeloid|2018-2022
0-19|2.1|2.2|2.1|8741|Mortality|408731990|All Cancer Sites Combined|2018-2022
0-19|0.2|0.3|0.2|1019|Mortality|408731990|Bones and Joints|2018-2022
0-19|0.6|0.6|0.6|2550|Mortality|408731990|Brain and Other Nervous System|2018-2022
0-19|0.0|0.0|0.0|41|Mortality|408731990|Hodgkin Lymphoma|2018-2022
0-19|0.1|0.1|0.1|243|Mortality|408731990|Kidney and Renal Pelvis|2018-2022
0-19|0.5|0.5|0.5|2101|Mortality|408731990|Leukemia|2018-2022
0-19|0.1|0.1|0.1|246|Mortality|408731990|Non-Hodgkin Lymphoma|2018-2022
0-19|0.4|0.4|0.4|1711|Mortality|408731990|Other|2018-2022
0-19|0.2|0.2|0.2|830|Mortality|408731990|Soft Tissue|2018-2022
0-14|0.2|0.3|0.2|136|Mortality|60613145|Acute Lymphocytic|2019
0-14|0.2|0.2|0.2|111|Mortality|60613145|Acute Myeloid|2019
0-14|1.7|1.9|1.8|1115|Mortality|60613145|All Cancer Sites Combined|2019
0-14|0.1|0.2|0.1|73|Mortality|60613145|Bones and Joints|2019
0-14|0.6|0.7|0.6|381|Mortality|60613145|Brain and Other Nervous System|2019
0-14|~|~|~|~|Mortality|60613145|Hodgkin Lymphoma|2019
0-14|0.0|0.1|0.1|35|Mortality|60613145|Kidney and Renal Pelvis|2019
0-14|0.4|0.5|0.5|292|Mortality|60613145|Leukemia|2019
0-14|0.0|0.1|0.0|23|Mortality|60613145|Non-Hodgkin Lymphoma|2019
0-14|0.3|0.4|0.4|234|Mortality|60613145|Other|2019
0-14|0.1|0.2|0.1|77|Mortality|60613145|Soft Tissue|2019
0-19|0.2|0.3|0.2|189|Mortality|81679568|Acute Lymphocytic|2019
0-19|0.1|0.2|0.2|139|Mortality|81679568|Acute Myeloid|2019
0-19|2.0|2.2|2.1|1704|Mortality|81679568|All Cancer Sites Combined|2019
0-19|0.2|0.3|0.2|191|Mortality|81679568|Bones and Joints|2019
0-19|0.6|0.7|0.6|513|Mortality|81679568|Brain and Other Nervous System|2019
0-19|~|~|~|~|Mortality|81679568|Hodgkin Lymphoma|2019
0-19|0.0|0.1|0.1|46|Mortality|81679568|Kidney and Renal Pelvis|2019
0-19|0.4|0.5|0.5|405|Mortality|81679568|Leukemia|2019
0-19|0.1|0.1|0.1|65|Mortality|81679568|Non-Hodgkin Lymphoma|2019
0-19|0.4|0.5|0.4|342|Mortality|81679568|Other|2019
0-19|0.1|0.2|0.2|137|Mortality|81679568|Soft Tissue|2019
0-14|0.2|0.2|0.2|118|Mortality|60590323|Acute Lymphocytic|2020
0-14|0.1|0.2|0.2|101|Mortality|60590323|Acute Myeloid|2020
0-14|1.8|2.0|1.9|1153|Mortality|60590323|All Cancer Sites Combined|2020
0-14|0.1|0.2|0.1|90|Mortality|60590323|Bones and Joints|2020
0-14|0.6|0.7|0.6|393|Mortality|60590323|Brain and Other Nervous System|2020
0-14|~|~|~|~|Mortality|60590323|Hodgkin Lymphoma|2020
0-14|0.0|0.1|0.1|39|Mortality|60590323|Kidney and Renal Pelvis|2020
0-14|0.4|0.5|0.5|276|Mortality|60590323|Leukemia|2020
0-14|0.0|0.0|0.0|17|Mortality|60590323|Non-Hodgkin Lymphoma|2020
0-14|0.4|0.5|0.4|244|Mortality|60590323|Other|2020
0-14|0.1|0.2|0.2|93|Mortality|60590323|Soft Tissue|2020
0-19|0.2|0.2|0.2|178|Mortality|82523116|Acute Lymphocytic|2020
0-19|0.1|0.2|0.2|133|Mortality|82523116|Acute Myeloid|2020
0-19|2.0|2.2|2.1|1702|Mortality|82523116|All Cancer Sites Combined|2020
0-19|0.2|0.3|0.2|196|Mortality|82523116|Bones and Joints|2020
0-19|0.6|0.7|0.6|522|Mortality|82523116|Brain and Other Nervous System|2020
0-19|~|~|~|~|Mortality|82523116|Hodgkin Lymphoma|2020
0-19|0.0|0.1|0.1|50|Mortality|82523116|Kidney and Renal Pelvis|2020
0-19|0.4|0.5|0.5|392|Mortality|82523116|Leukemia|2020
0-19|0.0|0.1|0.0|33|Mortality|82523116|Non-Hodgkin Lymphoma|2020
0-19|0.4|0.5|0.4|348|Mortality|82523116|Other|2020
0-19|0.2|0.2|0.2|154|Mortality|82523116|Soft Tissue|2020
0-14|0.2|0.3|0.2|134|Mortality|59928437|Acute Lymphocytic|2021
0-14|0.1|0.2|0.1|82|Mortality|59928437|Acute Myeloid|2021
0-14|1.8|2.0|1.9|1130|Mortality|59928437|All Cancer Sites Combined|2021
0-14|0.1|0.1|0.1|73|Mortality|59928437|Bones and Joints|2021
0-14|0.6|0.7|0.6|391|Mortality|59928437|Brain and Other Nervous System|2021
0-14|~|~|~|~|Mortality|59928437|Hodgkin Lymphoma|2021
0-14|0.0|0.1|0.1|39|Mortality|59928437|Kidney and Renal Pelvis|2021
0-14|0.4|0.5|0.4|267|Mortality|59928437|Leukemia|2021
0-14|0.0|0.1|0.1|32|Mortality|59928437|Non-Hodgkin Lymphoma|2021
0-14|0.3|0.4|0.4|231|Mortality|59928437|Other|2021
0-14|0.1|0.2|0.2|96|Mortality|59928437|Soft Tissue|2021
0-19|0.2|0.3|0.2|192|Mortality|81499734|Acute Lymphocytic|2021
0-19|0.1|0.2|0.2|124|Mortality|81499734|Acute Myeloid|2021
0-19|2.0|2.2|2.1|1722|Mortality|81499734|All Cancer Sites Combined|2021
0-19|0.2|0.3|0.2|202|Mortality|81499734|Bones and Joints|2021
0-19|0.6|0.7|0.6|503|Mortality|81499734|Brain and Other Nervous System|2021
0-19|~|~|~|~|Mortality|81499734|Hodgkin Lymphoma|2021
0-19|0.0|0.1|0.1|48|Mortality|81499734|Kidney and Renal Pelvis|2021
0-19|0.4|0.5|0.5|395|Mortality|81499734|Leukemia|2021
0-19|0.0|0.1|0.1|54|Mortality|81499734|Non-Hodgkin Lymphoma|2021
0-19|0.4|0.5|0.4|346|Mortality|81499734|Other|2021
0-19|0.2|0.2|0.2|167|Mortality|81499734|Soft Tissue|2021
0-14|0.2|0.3|0.2|133|Mortality|59437387|Acute Lymphocytic|2022
0-14|0.1|0.2|0.2|105|Mortality|59437387|Acute Myeloid|2022
0-14|1.8|2.0|1.9|1141|Mortality|59437387|All Cancer Sites Combined|2022
0-14|0.1|0.2|0.1|87|Mortality|59437387|Bones and Joints|2022
0-14|0.6|0.7|0.6|367|Mortality|59437387|Brain and Other Nervous System|2022
0-14|~|~|~|~|Mortality|59437387|Hodgkin Lymphoma|2022
0-14|0.1|0.1|0.1|43|Mortality|59437387|Kidney and Renal Pelvis|2022
0-14|0.4|0.6|0.5|293|Mortality|59437387|Leukemia|2022
0-14|0.0|0.1|0.0|23|Mortality|59437387|Non-Hodgkin Lymphoma|2022
0-14|0.3|0.4|0.4|223|Mortality|59437387|Other|2022
0-14|0.1|0.2|0.2|103|Mortality|59437387|Soft Tissue|2022
0-19|0.2|0.3|0.3|212|Mortality|81073179|Acute Lymphocytic|2022
0-19|0.2|0.2|0.2|157|Mortality|81073179|Acute Myeloid|2022
0-19|2.1|2.3|2.2|1772|Mortality|81073179|All Cancer Sites Combined|2022
0-19|0.2|0.3|0.3|235|Mortality|81073179|Bones and Joints|2022
0-19|0.5|0.6|0.6|480|Mortality|81073179|Brain and Other Nervous System|2022
0-19|~|~|~|~|Mortality|81073179|Hodgkin Lymphoma|2022
0-19|0.0|0.1|0.1|49|Mortality|81073179|Kidney and Renal Pelvis|2022
0-19|0.5|0.6|0.6|450|Mortality|81073179|Leukemia|2022
0-19|0.0|0.1|0.0|39|Mortality|81073179|Non-Hodgkin Lymphoma|2022
0-19|0.4|0.5|0.4|329|Mortality|81073179|Other|2022
0-19|0.2|0.3|0.2|180|Mortality|81073179|Soft Tissue|2022
